Pubmed ID Article Details
12722831 Ishizawa T et al.: Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J. Neuropathol. Exp. Neurol. 2003 62: 389-397
9930729 Lesort M et al.: Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J. Neurochem. 1999 72: 576-584
8250835 Sutherland C et al.: Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 1993 296: 15-19
8382613 Hughes K et al.: Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 1993 12: 803-808
9685326 Pap M et al.: Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem. 1998 273
8978681 Alessi DR et al.: Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996 15: 6541-6551
8978681 Alessi DR et al.: Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO J. 1996 15: 6541-6551
8978681 Alessi DR et al.: Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO J. 1996 15: 6541-6551
11527574 Grimes CA et al.: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog. Neurobiol. 2001 65: 391-426
9468292 Welsh GI et al.: Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 1998 421: 125-130
18852354 Schaffer BA et al.: Association of GSK3B with Alzheimer disease and frontotemporal dementia Arch. Neurol. 2008 65: 1368-1374
1899151 Moore CK et al.: Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization Transplant. Proc. 1991 23: 1055-1058
18932008 Mendes CT et al.: Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease Eur Arch Psychiatry Clin Neurosci 2009 259: 16-22
16944319 Verdile G et al.: The role of presenilin and its interacting proteins in the biogenesis of Alzheimers beta amyloid. Neurochem. Res. 2007 32: 609-623
16641999 Chen F et al.: TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity Nature 2006 440: 1208-1212
16641999 Chen F et al.: TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 2006 440: 1208-1212
19779148 Kang JE et al.: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009 326: 1005-1007
10993067 Yu G et al.: Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing Nature 2000 407: 48-54
10993067 Yu G et al.: Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 2000 407: 48-54
12660785 Takasugi N et al.: The role of presenilin cofactors in the gamma-secretase complex. Nature 2003 422: 438-441
12032140 Yang DS et al.: Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J. Biol. Chem. 2002 277
12032140 Yang DS et al.: Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins J. Biol. Chem. 2002 277
12044882 Tomita T et al.: Complex N-glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments. FEBS Lett. 2002 520: 117-121
12048259 Edbauer D et al.: Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc. Natl. Acad. Sci. U.S.A. 2002 99: 8666-8671
14981233 Schubert M et al.: Role for neuronal insulin resistance in neurodegenerative diseases Proc. Natl. Acad. Sci. U.S.A. 2004 101: 3100-3105
19144826 Lee HK et al.: The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol. Biol. Cell 2009 20: 1533-1544
19144826 Lee HK et al.: The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid Mol. Biol. Cell 2009 20: 1533-1544
19712582 de la Monte SM et al.: Insulin resistance and Alzheimers disease BMB Rep 2009 42: 475-481
12904469 Schubert M et al.: Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation J. Neurosci. 2003 23: 7084-7092
1904481 Perry G et al.: Neuropil threads of Alzheimers disease show a marked alteration of the normal cytoskeleton J. Neurosci. 1991 11: 1748-1755
8592647 Takashima A et al.: Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons. Neurosci. Lett. 1995 198: 83-86
15094077 Watson GS et al.: Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimers disease Eur. J. Pharmacol. 2004 490: 97-113
10672254 Hoyer S et al.: Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats Ann. N. Y. Acad. Sci. 1999 893: 301-303
11943765 Leem JY et al.: Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J. Biol. Chem. 2002 277
11146649 Sato N et al.: Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression. Nat. Cell Biol. 2000 2: 863-870
19940183 Rudrabhatla P et al.: Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins. J. Neurosci. 2009 29
12846562 Beher D et al.: In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand Biochemistry 2003 42: 8133-8142
15189355 Shirotani K et al.: Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: identification of nicastrin mutants that selectively interact with APH-1. J. Neurochem. 2004 89: 1520-1527
15676027 Uchida Y et al.: Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimers disease. Genes Cells 2005 10: 165-179
18635547 Rudrabhatla P et al.: Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein. J. Biol. Chem. 2008 283
18635547 Rudrabhatla P et al.: Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein J. Biol. Chem. 2008 283
19661622 Popp J et al.: Homocysteine metabolism and cerebrospinal fluid markers for Alzheimers disease. J. Alzheimers Dis. 2009 18: 819-828
19661623 Goni-Oliver P et al.: Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimers disease J. Alzheimers Dis. 2009 18: 843-848
17626162 Kesavapany S et al.: Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons Mol. Biol. Cell 2007 18: 3645-3655
17626162 Kesavapany S et al.: Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons. Mol. Biol. Cell 2007 18: 3645-3655
10672251 Frolich L et al.: A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimers disease. Ann. N. Y. Acad. Sci. 1999 893: 290-293
10231383 Li BS et al.: Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells. Eur. J. Biochem. 1999 262: 211-217
10670439 Boyt AA et al.: The effect of insulin and glucose on the plasma concentration of Alzheimers amyloid precursor protein. Neuroscience 2000 95: 727-734
17298085 Zhou S et al.: Regulation of gamma-secretase activity in Alzheimers disease. Biochemistry 2007 46: 2553-2563
12761548 Phiel CJ et al.: GSK-3alpha regulates production of Alzheimers disease amyloid-beta peptides. Nature 2003 423: 435-439
19090986 Cashman JR et al.: Immune defects in Alzheimers disease: new medications development. BMC Neurosci 2008 9: S13
10341227 Kang DE et al.: Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimers disease-linked PS1 mutants in the beta-catenin-signaling pathway J. Neurosci. 1999 19: 4229-4237
12297048 Kang DE et al.: Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis Cell 2002 110: 751-762
11554609 Klunk WE et al.: Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 2001 69: 1471-1484
14651959 Ryder J et al.: Divergent roles of GSK3 and CDK5 in APP processing Biochem. Biophys. Res. Commun. 2003 312: 922-929
14651959 Ryder J et al.: Divergent roles of GSK3 and CDK5 in APP processing. Biochem. Biophys. Res. Commun. 2003 312: 922-929
18189321 Chen Q et al.: Loss of presenilin function causes Alzheimers disease-like neurodegeneration in the mouse. J. Neurosci. Res. 2008 86: 1615-1625
19337449 Gotz J et al.: An update on the toxicity of Abeta in Alzheimers disease. Neuropsychiatr Dis Treat 2008 4: 1033-1042
17708691 Crouch PJ et al.: Mitochondria in aging and Alzheimers disease. Rejuvenation Res 2007 10: 349-357
19268425 Celsi F et al.: Mitochondria, calcium and cell death: a deadly triad in neurodegeneration Biochim. Biophys. Acta 2009 1787: 335-344
9051814 Guo Q et al.: Alzheimers PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide Neuroreport 1996 8: 379-383
16394273 Lee SY et al.: PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release FASEB J. 2006 20: 151-153
15659604 Crouch PJ et al.: Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42 J. Neurosci. 2005 25: 672-679
15170327 Su Y et al.: Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing Biochemistry 2004 43: 6899-6908
15170327 Su Y et al.: Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing Biochemistry 2004 43: 6899-6908
16014628 Feyt C et al.: Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3. J. Biol. Chem. 2005 280
15485501 Good PF et al.: A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimers disease. J. Neurochem. 2004 91: 716-736
15634781 Ma G et al.: APH-1a is the principal mammalian APH-1 isoform present in gamma-secretase complexes during embryonic development. J. Neurosci. 2005 25: 192-198
19478559 Yoon EJ et al.: Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis Exp. Mol. Med. 2009 41: 611-617
15466863 Cole AR et al.: GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. J. Biol. Chem. 2004 279
15466863 Cole AR et al.: GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons J. Biol. Chem. 2004 279
19793966 Jinwal UK et al.: Chemical manipulation of hsp70 ATPase activity regulates tau stability J. Neurosci. 2009 29
19449461 Koren J 3rd et al.: Chaperone signalling complexes in Alzheimers disease J. Cell. Mol. Med. 2009 13: 619-630
16724068 Uehara T et al.: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration Nature 2006 441: 513-517
16724068 Uehara T et al.: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration Nature 2006 441: 513-517
16724068 Uehara T et al.: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006 441: 513-517
12522269 Dou F et al.: Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. U.S.A. 2003 100: 721-726
12522269 Dou F et al.: Chaperones increase association of tau protein with microtubules Proc. Natl. Acad. Sci. U.S.A. 2003 100: 721-726
14962978 Petrucelli L et al.: CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation Hum. Mol. Genet. 2004 13: 703-714
18061943 Bjorkdahl C et al.: Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J. Neurosci. Res. 2008 86: 1343-1352
18061943 Bjorkdahl C et al.: Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments J. Neurosci. Res. 2008 86: 1343-1352
19946466 Bonda DJ et al.: Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease Aging (Albany NY) 2009 1: 382-388
20237268 Biswas SC et al.: Sertad1 plays an essential role in developmental and pathological neuron death J. Neurosci. 2010 30: 3973-3982
19647374 Bajic VP et al.: The X-chromosome instability phenotype in Alzheimers disease: a clinical sign of accelerating aging? }, authors { names std { { name ml Bajic VP, affil str Institute of Biomedical Research, Galenika ad, 11000 Belgrade, Serbia. vladanbajic@yahoo.com }, { name ml Spremo-Potparevic B }, { name ml Zivkovic L }, { name ml Bonda DJ }, { name ml Siedlak SL }, { name ml Casadesus G }, { name ml Lee HG }, { name ml Smith MA } } }, from journal { title { iso-jta Med. Hypotheses, ml-jta Med Hypotheses, issn 1532-2777, name Medical hypotheses }, imp { date std { year 2009, month 12 }, volume 73, issue 6, pages 917-920, language eng, pubstatus ppublish, history { { pubstatus received, date std { year 2009, month 6, day 23 } }, { pubstatus accepted, date std { year 2009, month 6, day 24 } }, { pubstatus aheadofprint, date std { year 2009, month 7, day 31 } }, { pubstatus other, date std { year 2009, month 8, day 4, hour 9, minute 0 } }, { pubstatus pubmed, date std { year 2009, month 8, day 4, hour 9, minute 0 } }, { pubstatus medline, date std { year 2010, month 3, day 2, hour 6, minute 0 } } } } }, ids { pii S0306-9877(09)00478-2, doi 10.1016/j.mehy.2009.06.046, pubmed 19647374, other { db pmc, tag str PMC2787990 }, other { db mid, tag str NIHMS136441 }, other { db ELocationID doi, tag str 10.1016/j.mehy.2009.06.046 } } }, abstract Premature centromere division, or premature centromere separation (PCS), occurs when chromatid separation is dysfunctional, occurring earlier than usual during the interphase stage of mitosis. This phenomenon, seen in Roberts syndrome and various cancers, has also been documented in peripheral as well as neuronal cells of Alzheimers disease (AD). In the latter instances, fluorescent in situ hybridization (FISH), applied to the centromere region of the X-chromosome in interphase nuclei of lymphocytes from peripheral blood in AD patients, demonstrated premature chromosomal separation before mitotic metaphase directly after completion of DNA replication in G(2) phase of the cell cycle. Furthermore, and perhaps unexpectedly given the presumptive post-mitotic status of terminally differentiated neurons, neurons in AD patients also showed significantly increased levels of PCS of the X-chromosome. Taken together with other phenomena such as cell cycle re-activation and ectopic re-expression of cyclins and cyclin dependent proteins, we propose that AD is an oncogenic phenotype leading to accelerated aging of the affected brain Med. Hypotheses 2009 73: 917-920
12624792 Pei JJ et al.: Role of protein kinase B in Alzheimers neurofibrillary pathology. Acta Neuropathol. 2003 105: 381-392
17276679 Ansar S et al.: A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity. Bioorg. Med. Chem. Lett. 2007 17: 1984-1990
14963027 Shimura H et al.: Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival. J. Biol. Chem. 2004 279
15132984 Nemes Z et al.: Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimers neurofibrillary tangles. FASEB J. 2004 18: 1135-1137
15615647 Kosik KS et al.: Phosphorylated tau and the neurodegenerative foldopathies. Biochim. Biophys. Acta 2005 1739: 298-310
14612456 Shimura H et al.: CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival J. Biol. Chem. 2004 279: 4869-4876
12888622 Gamblin TC et al.: Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimers disease Proc. Natl. Acad. Sci. U.S.A. 2003 100
20357768 de Calignon A et al.: Caspase activation precedes and leads to tangles. Nature 2010 464: 1201-1204
19191039 Sun AY et al.: Botanical phenolics and brain health Neuromolecular Med. 2008 10: 259-274
12793519 Joseph JA et al.: Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 2003 6: 153-162
16177050 Rezai-Zadeh K et al.: Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice J. Neurosci. 2005 25: 8807-8814
16177050 Rezai-Zadeh K et al.: Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice J. Neurosci. 2005 25: 8807-8814
16624814 Obregon DF et al.: ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein J. Biol. Chem. 2006 281
15579468 Kanekura K et al.: A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J. Biol. Chem. 2005 280: 4532-4543
16636099 Chen F et al.: Reductions in levels of the Alzheimers amyloid beta peptide after oral administration of ginsenosides FASEB J. 2006 20: 1269-1271
16636099 Chen F et al.: Reductions in levels of the Alzheimers amyloid beta peptide after oral administration of ginsenosides FASEB J. 2006 20: 1269-1271
15277073 Chauhan NB et al.: Anti-amyloidogenic effect of Allium sativum in Alzheimers transgenic model Tg2576 J Herb Pharmacother 2003 3: 95-107
20385830 Han W et al.: Linking type 2 diabetes and Alzheimers disease Proc. Natl. Acad. Sci. U.S.A. 2010 107: 6557-6558
20231468 Takeda S et al.: Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes Proc. Natl. Acad. Sci. U.S.A. 2010 107: 7036-7041
11880515 Westerman MA et al.: The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimers disease J. Neurosci. 2002 22: 1858-1867
19242462 Cisse M et al.: Alzheimers disease: A prion protein connection. Nature 2009 457: 1090-1091
19829367 Mucke L et al.: Neuroscience: Alzheimers disease Nature 2009 461: 895-897
17082448 Roberson ED et al.: 100 years and counting: prospects for defeating Alzheimers disease. Science 2006 314: 781-784
16842945 Chauhan NB et al.: Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimers transgenic model Tg2576 J Ethnopharmacol 2006 108: 385-394
17380553 Chauhan NB et al.: Amelioration of early cognitive deficits by aged garlic extract in Alzheimers transgenic mice Phytother Res 2007 21: 629-640
17380553 Chauhan NB et al.: Amelioration of early cognitive deficits by aged garlic extract in Alzheimers transgenic mice. Phytother Res 2007 21: 629-640
14637120 Stackman RW et al.: Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimers disease by chronic Ginkgo biloba treatment Exp. Neurol. 2003 184: 510-520
17086105 Garcia-Alloza M et al.: Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model J. Neuropathol. Exp. Neurol. 2006 65: 1082-1089
15010693 Tohda C et al.: Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins. Neuropsychopharmacology 2004 29: 860-868
17010630 Hartman RE et al.: Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimers disease Neurobiol. Dis. 2006 24: 506-515
19104446 Julien C et al.: Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2009 68: 48-58
19548013 Tong Y et al.: COL25A1 triggers and promotes Alzheimers disease-like pathology in vivo Neurogenetics 2010 11: 41-52
20126630 Frykman S et al.: Synaptic and endosomal localization of active gamma-secretase in rat brain. PLoS ONE 2010 5: E8948
16183991 Chen J et al.: SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling J. Biol. Chem. 2005 280
20061625 Huesa G et al.: Altered distribution of RhoA in Alzheimers disease and AbetaPP overexpressing mice J. Alzheimers Dis. 2010 19: 37-56
12603837 Siman R et al.: Localization of presenilin-nicastrin complexes and gamma-secretase activity to the trans-Golgi network. J. Neurochem. 2003 84: 1143-1153
19712581 Chung SH et al.: Aberrant phosphorylation in the pathogenesis of Alzheimers disease BMB Rep 2009 42: 467-474
10814741 Yasojima K et al.: Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Res. 2000 865: 116-120
10412011 Yasojima K et al.: Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA. Brain Res. 1999 831: 301-305
10924763 Schwab C et al.: Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases Neurobiol. Aging 2000 21: 503-510
15345711 Beglopoulos V et al.: Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J. Biol. Chem. 2004 279
19521544 Engmann O et al.: Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimers Disease. Front Mol Neurosci 2009 2: 2
18691386 Sun KH et al.: Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction J. Neurochem. 2008 107: 265-278
9038181 Poon RY et al.: Identification of functional domains in the neuronal Cdk5 activator protein. J. Biol. Chem. 1997 272: 5703-5708
10604467 Patrick GN et al.: Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 1999 402: 615-622
19776350 Sun KH et al.: Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimers disease. Mol. Biol. Cell 2009 20: 4611-4619
20462385 Candore G et al.: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications Rejuvenation Res 2010 13: 301-313
11329064 Wyss-Coray T et al.: TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice Nat. Med. 2001 7: 612-618
18801740 Lukiw WJ et al.: An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells J. Biol. Chem. 2008 283
17905482 Letiembre M et al.: Screening of innate immune receptors in neurodegenerative diseases: a similar pattern Neurobiol. Aging 2009 30: 759-768
11749806 Zeng HH et al.: Antioxidant properties of phenolic diterpenes from Rosmarinus officinalis Acta Pharmacol. Sin. 2001 22: 1094-1098
2529544 Griffin WS et al.: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 1989 86: 7611-7615
15290893 Mrak RE et al.: Trisomy 21 and the brain J. Neuropathol. Exp. Neurol. 2004 63: 679-685
17360493 Flajolet M et al.: Regulation of Alzheimers disease amyloid-beta formation by casein kinase I Proc. Natl. Acad. Sci. U.S.A. 2007 104: 4159-4164
17094809 Wilkinson BL et al.: The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimers disease J Neuroinflammation 2006 3: 30
20552018 Schonrock N et al.: Neuronal microRNA deregulation in response to Alzheimers disease amyloid-beta PLoS ONE 2010 5
20552018 Schonrock N et al.: Neuronal microRNA deregulation in response to Alzheimers disease amyloid-beta. PLoS ONE 2010 5
19406203 Sethi P et al.: Micro-RNA abundance and stability in human brain: specific alterations in Alzheimers disease temporal lobe neocortex Neurosci. Lett. 2009 459: 100-104
20489155 Wang WX et al.: miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 2010 177: 334-345
20126538 Nunez-Iglesias J et al.: Joint genome-wide profiling of miRNA and mRNA expression in Alzheimers disease cortex reveals altered miRNA regulation PLoS ONE 2010 5: E8898
20202123 Shioya M et al.: Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3 Neuropathol. Appl. Neurobiol. 2010 36: 320-330
12787059 Castegna A et al.: Proteomic identification of nitrated proteins in Alzheimers disease brain J. Neurochem. 2003 85: 1394-1401
20472889 Arendt T et al.: Selective cell death of hyperploid neurons in Alzheimers disease Am. J. Pathol. 2010 177: 15-20
10867782 Hock C et al.: Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas Arch. Neurol. 2000 57: 846-851
15857398 Wang J et al.: Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimers disease J. Neurochem. 2005 93: 953-962
11733217 Butterfield DA et al.: Evidence of oxidative damage in Alzheimers disease brain: central role for amyloid beta-peptide Trends Mol Med 2001 7: 548-554
19654187 Wang Y et al.: Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing Hum. Mol. Genet. 2009 18: 4153-4170
17485462 Ko MH et al.: The sterol carrier protein SCP-x/pro-SCP-2 gene has transcriptional activity and regulates the Alzheimer disease gamma-secretase J. Biol. Chem. 2007 282
20451302 Persengiev S et al.: Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis Neurobiol. Aging 2011 32: 2316
20413881 Nelson PT et al.: MiR-107 is reduced in Alzheimers disease brain neocortex: validation study J. Alzheimers Dis. 2010 21: 75-79
20110602 Ciaramella A et al.: Increased pro-inflammatory response by dendritic cells from patients with Alzheimers disease J. Alzheimers Dis. 2010 19: 559-572
20134203 Morales I et al.: Neuroimmunomodulation in the pathogenesis of Alzheimers disease Neuroimmunomodulation 2010 17: 202-204
20122289 Zotova E et al.: Inflammation in Alzheimers disease: relevance to pathogenesis and therapy Alzheimers Res Ther 2010 2: 1
20696495 Wilkinson BL et al.: Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimers disease Neurobiol. Aging 2012 33: 197
20696495 Wilkinson BL et al.: Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimers disease Neurobiol. Aging 2012 33: 197
16645044 Wang R et al.: Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia FASEB J. 2006 20: 1275-1277
16645641 Xu Y et al.: Intracellular domains of amyloid precursor-like protein 2 interact with CP2 transcription factor in the nucleus and induce glycogen synthase kinase-3beta expression Cell Death Differ. 2007 14: 79-91
20594619 Robakis NK et al.: Mechanisms of AD neurodegeneration may be independent of Abeta and its derivatives Neurobiol. Aging 2011 32: 372-379
19641596 Zhang C et al.: Presenilins are essential for regulating neurotransmitter release Nature 2009 460: 632-636
18184791 Baki L et al.: Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signaling J. Neurosci. 2008 28: 483-490
19261853 Liu Z et al.: Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinsons disease Proc. Natl. Acad. Sci. U.S.A. 2009 106: 4635-4640
20739979 Ledford H et al.: Key Alzheimers findings questioned. Nature 2010 466: 1031
20552043 Guglielmotto M et al.: Oxidative stress mediates the pathogenic effect of different Alzheimers disease risk factors Front Aging Neurosci 2010 2: 3
20817278 Duce JA et al.: Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimers disease Cell 2010 142: 857-867
19021541 Rogers JT et al.: Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimers disease Biochem. Soc. Trans. 2008 36: 1282-1287
20631161 Brewer GJ et al.: Copper and ceruloplasmin abnormalities in Alzheimers disease Am J Alzheimers Dis Other Demen 2010 25: 490-497
19166904 Cahill CM et al.: Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases Biochim. Biophys. Acta 2009 1790: 615-628
19631630 Yao L et al.: Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimers disease Brain Res. 2009 1291: 133-139
18400211 Cheng CY et al.: Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats Brain Res. 2008 1209: 136-150
16205720 Gaeta A et al.: The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy Br. J. Pharmacol. 2005 146: 1041-1059
18687504 Jo DG et al.: Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimers disease Neurobiol. Aging 2010 31: 917-925
18687504 Jo DG et al.: Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimers disease Neurobiol. Aging 2010 31: 917-925
19965584 Vedin I et al.: Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study J. Lipid Res. 2010 51: 1179-1185
17014365 Andrews NC et al.: Iron homeostasis Annu. Rev. Physiol. 2007 69: 69-85
19225519 Nikolaev A et al.: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases Nature 2009 457: 981-989
19898775 Wang SM et al.: Role of hepcidin in murine brain iron metabolism Cell. Mol. Life Sci. 2010 67: 123-133
18585350 Dreses-Werringloer U et al.: A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimers disease risk Cell 2008 133: 1149-1161
20619502 Liu W et al.: MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimers-associated pathogenesis in SAMP8 mice Neurobiol. Aging 2012 33: 522-534
19090996 Block ML et al.: NADPH oxidase as a therapeutic target in Alzheimers disease BMC Neurosci 2008 9: S8
20442493 Young KJ et al.: The mitochondrial secret(ase) of Alzheimers disease J. Alzheimers Dis. 2010 20: S381-S400
16551656 Manczak M et al.: Mitochondria are a direct site of A beta accumulation in Alzheimers disease neurons: implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet. 2006 15: 1437-1449
20463396 Di Filippo M et al.: Mitochondria and the link between neuroinflammation and neurodegeneration J. Alzheimers Dis. 2010 20: S369-S379
20463408 Morais VA et al.: Mitochondria dysfunction and neurodegenerative disorders: cause or consequence J. Alzheimers Dis. 2010 20: S255-S263
15087549 Lustbader JW et al.: ABAD directly links Abeta to mitochondrial toxicity in Alzheimers disease Science 2004 304: 448-452
18757748 Hansson Petersen CA et al.: The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae Proc. Natl. Acad. Sci. U.S.A. 2008 105
15456764 Hansson CA et al.: Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria J. Biol. Chem. 2004 279
20655099 Ittner LM et al.: Dendritic function of tau mediates amyloid-beta toxicity in Alzheimers disease mouse models Cell 2010 142: 387-397
20691893 Haass C et al.: Fyn-tau-amyloid: a toxic triad Cell 2010 142: 356-358
17088888 Lin MT et al.: Alzheimers APP mangles mitochondria Nat. Med. 2006 12: 1241-1243
12196559 Stein TD et al.: Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways J. Neurosci. 2002 22: 7380-7388
12196559 Stein TD et al.: Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways J. Neurosci. 2002 22: 7380-7388
14675736 Cardoso SM et al.: Cytochrome c oxidase is decreased in Alzheimers disease platelets Neurobiol. Aging 2004 25: 105-110
12270688 Casley CS et al.: Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons Neurobiol. Dis. 2002 10: 258-267
19605646 Wang X et al.: Impaired balance of mitochondrial fission and fusion in Alzheimers disease J. Neurosci. 2009 29: 9090-9103
15591653 Keil U et al.: Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure Pol J Pharmacol 2004 56: 631-634
20816785 Anekonda TS et al.: L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimers disease. Neurobiol. Dis. 2011 41: 62-70
21134458 Rozkalne A et al.: Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice Neurobiol. Dis. 2011 41: 650-654
20887789 Batlevi Y et al.: Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging Neurobiol. Dis. 2011 43: 46-51
20888417 Massone S et al.: 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease Neurobiol. Dis. 2011 41: 308-317
21081164 Rohn TT et al.: Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimers disease brain Neurobiol. Dis. 2011 43: 68-78
20732422 Yamamoto A et al.: The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration Neurobiol. Dis. 2011 43: 17-28
12270682 Janciauskiene S et al.: Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimers disease Neurobiol. Dis. 2002 10: 187-200
21270867 Ledford H et al.: Alzheimers-disease probe nears approval. Nature 2011 469: 458
20551690 Kaiser E et al.: Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimers disease. Neurodegener Dis 2010 7: 251-259
18037246 Padmashri R et al.: Glutamate transporter blockade affects Ca(2+) responses in astrocytes. Neuroscience 2008 151: 56-62
19897719 Rhein V et al.: Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimers disease mice. Proc. Natl. Acad. Sci. U.S.A. 2009 106
19035593 Frydman-Marom A et al.: Cognitive-performance recovery of Alzheimers disease model mice by modulation of early soluble amyloidal assemblies. Angew. Chem. Int. Ed. Engl. 2009 48: 1981-1986
20709030 Wang H et al.: miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimers disease targets TGF-beta type II receptor. Brain Res. 2010 1357: 166-174
20937840 Cui JG et al.: Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease J. Biol. Chem. 2010 285
18838197 Vargas T et al.: Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis Neurobiol. Aging 2010 31: 1569-1581
21062284 Smith P et al.: In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J. Neurochem. 2011 116: 240-247
18434550 Hebert SS et al.: Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimers disease correlates with increased BACE1/beta-secretase expression Proc. Natl. Acad. Sci. U.S.A. 2008 105: 6415-6420
16599941 Wilhelmus MM et al.: Specific association of small heat shock proteins with the pathological hallmarks of Alzheimers disease brains Neuropathol. Appl. Neurobiol. 2006 32: 119-130
16611012 Gomez-Ramos A et al.: Inhibition of GSK3 dependent tau phosphorylation by metals. Curr Alzheimer Res 2006 3: 123-127
19795195 Pickrell AM et al.: The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation. J. Bioenerg. Biomembr. 2009 41: 453-456
19342591 Cho DH et al.: S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009 324: 102-105
19050078 Wang X et al.: Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U.S.A. 2008 105
17715058 Fukui H et al.: Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimers disease Proc. Natl. Acad. Sci. U.S.A. 2007 104
19091971 Liu Y et al.: Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimers disease. J. Neurosci. 2008 28
19118186 Sato S et al.: Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1 J. Neurosci. 2008 28
19118186 Sato S et al.: Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. J. Neurosci. 2008 28
21208686 van Beek AH et al.: Oscillations in cerebral blood flow and cortical oxygenation in Alzheimers disease Neurobiol. Aging 2012 33: 428
19063999 Kennelly SP et al.: Blood pressure and the risk for dementia: a double edged sword Ageing Res. Rev. 2009 8: 61-70
18692159 Chung HY et al.: Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009 8: 18-30
18313368 Chung JH et al.: Molecular mechanism of PPAR in the regulation of age-related inflammation Ageing Res. Rev. 2008 7: 126-136
20170744 Vance JE et al.: Formation and function of apolipoprotein E-containing lipoproteins in the nervous system Biochim. Biophys. Acta 2010 1801: 806-818
20228251 Lee M et al.: Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J. 2010 24: 2533-2545
16025111 Snyder EM et al.: Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005 8: 1051-1058
18813209 Chiba T et al.: Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol. Psychiatry 2009 14: 206-222
20889807 Geldmacher DS et al.: Alzheimer disease prevention: focus on cardiovascular risk, not amyloid Cleve Clin J Med 2010 77: 689-704
19076444 Gibson GE et al.: Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimers disease Ann. N. Y. Acad. Sci. 2008 1147: 221-232
16472763 Clementi ME et al.: Alzheimers amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35. Biochem. Biophys. Res. Commun. 2006 342: 206-213
20933077 Zhang H et al.: Puerarin protects Alzheimers disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. Exp. Gerontol. 2011 46: 30-37
21461981 Bajic VP et al.: Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease Cell. Mol. Biol. Lett. 2011 16: 359-372
21421841 Jin M et al.: Soluble amyloid {beta}-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. U.S.A. 2011 108: 5819-5824
21349442 Bonda DJ et al.: The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations Lancet Neurol 2011 10: 275-279
21121893 Monteiro JP et al.: SIRT1 deacetylase activity and the maintenance of protein homeostasis in response to stress: an overview. Protein Pept. Lett. 2011 18: 167-173
16751189 Qin W et al.: Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 2006 281
17517621 De Ferrari GV et al.: Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimers disease. Proc. Natl. Acad. Sci. U.S.A. 2007 104: 9434-9439
21383494 Sultana R et al.: Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimers Disease: Insights into the Role of Oxidative Stress in Alzheimers Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder. J. Alzheimers Dis. 2011 24: 77-84
21187585 Schrag M et al.: Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimers disease. J. Alzheimers Dis. 2011 24: 137-149
21187587 Zhou R et al.: Association between Bone Mineral Density and the Risk of Alzheimers Disease. J. Alzheimers Dis. 2011 24: 101-108
21376707 Li W et al.: Regulation of matrix metalloproteinase 2 by oligomeric amyloid beta protein. Brain Res. 2011 1387: 141-148
21148560 Jawhar S et al.: Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice. J. Biol. Chem. 2011 286: 4454-4460
19863057 Buchholz M et al.: Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement. J. Med. Chem. 2009 52: 7069-7080
20128815 Manthey D et al.: The selective beta1-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities. Br. J. Pharmacol. 2010 159: 1264-1273
21288892 Huang KF et al.: Structures of Human Golgi-resident Glutaminyl Cyclase and Its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding. J. Biol. Chem. 2011 286
18836460 Schilling S et al.: Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimers disease-like pathology. Nat. Med. 2008 14: 1106-1111
19342064 Shenk JC et al.: The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimers disease J. Neurol. Sci. 2009 283: 199-206
20385883 Gu Y et al.: Food combination and Alzheimer disease risk: a protective diet Arch. Neurol. 2010 67: 699-706
20627092 Yamada K et al.: Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimers disease. Brain Res. 2010 1352: 176-186
20971085 Shi JQ et al.: Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains. Brain Res. 2011 1368: 239-247
18926603 Julien C et al.: High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol. Aging 2010 31: 1516-1531
19604602 DOnofrio M et al.: Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice. Neurobiol. Aging 2011 32: 1007-1022
16813604 Akomolafe A et al.: Genetic association between endothelial nitric oxide synthase and Alzheimer disease Clin. Genet. 2006 70: 49-56
21127294 Austin SA et al.: Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ. Res. 2010 107: 1498-1502
19604603 Portelius E et al.: A novel pathway for amyloid precursor protein processing Neurobiol. Aging 2011 32: 1090-1098
19604604 Liu RM et al.: Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimers disease. Neurobiol. Aging 2011 32: 1079-1089
19628305 Amadoro G et al.: Endogenous Abeta causes cell death via early tau hyperphosphorylation. Neurobiol. Aging 2011 32: 969-990
17534003 Gliebus G et al.: The influence of beta-blockers on delayed memory function in people with cognitive impairment. Am J Alzheimers Dis Other Demen 2007 22: 57-61
19805638 Takeda S et al.: Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 2009 54: 1345-1352
21633502 Bigalke B et al.: Adipocytokines and CD34 Progenitor Cells in Alzheimers Disease. PLoS ONE 2011 6
21297254 Mateos L et al.: Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimers disease J. Alzheimers Dis. 2011 24: 669-679
21368380 Fiala M et al.: MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimers disease by vitamin D and curcuminoids J. Alzheimers Dis. 2011 25: 135-144
21157028 Gelber RP et al.: Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J. Alzheimers Dis. 2011 23: 607-615
21321396 Carrasquillo MM et al.: Replication of BIN1 association with Alzheimers disease and evaluation of genetic interactions J. Alzheimers Dis. 2011 24: 751-758
21132329 Belbin O et al.: Investigation of 15 of the top candidate genes for late-onset Alzheimers disease. Hum. Genet. 2011 129: 273-282
21098976 Keller L et al.: The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimers disease risk: a prospective cohort study J. Alzheimers Dis. 2011 23: 461-469
21321400 Tiribuzi R et al.: Lysosomal beta-galactosidase and beta-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimers disease and type 2 diabetes mellitus J. Alzheimers Dis. 2011 24: 785-797
21321389 Echeverria V et al.: Cotinine reduces amyloid-beta aggregation and improves memory in Alzheimers disease mice J. Alzheimers Dis. 2011 24: 817-835
20413858 Carlsson CM et al.: Type 2 diabetes mellitus, dyslipidemia, and Alzheimers disease. J. Alzheimers Dis. 2010 20: 711-722
18376061 Carlsson CM et al.: Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimers disease. J. Alzheimers Dis. 2008 13: 187-197
21536132 Butterfield DA et al.: Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders Pharmacol. Res. 2011 64: 180-186
20847439 Murphy MP et al.: Changes in cognition and amyloid-beta processing with long term cholesterol reduction using atorvastatin in aged dogs. J. Alzheimers Dis. 2010 22: 135-150
21345168 Heneka MT et al.: Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimers disease. Curr Alzheimer Res 2011 8: 115-131
20639188 Gulaj E et al.: Kynurenine and its metabolites in Alzheimers disease patients Adv Med Sci 2010 55: 204-211
17049675 Urbanelli L et al.: Cathepsin D expression is decreased in Alzheimers disease fibroblasts. Neurobiol. Aging 2008 29: 12-22
21416488 Green KN et al.: ST101 induces a novel 17 kDa APP cleavage that precludes Abeta generation in vivo. Ann. Neurol. 2011 69: 831-844
11786245 Sly LM et al.: Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimers disease. Brain Res. Bull. 2001 56: 581-588
21466683 Kok EH et al.: CLU, CR1 and PICALM genes associate with Alzheimers-related senile plaques. Alzheimers Res Ther 2011 3: 12
21391232 Chibnik LB et al.: CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann. Neurol. 2011 69: 560-569
16515786 Pedersen WA et al.: Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice Exp. Neurol. 2006 199: 265-273
21280074 Chu J et al.: 5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo. Ann. Neurol. 2011 69: 34-46
21280075 Reitz C et al.: SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimers disease risk. Ann. Neurol. 2011 69: 47-64
21321391 Fragkouli A et al.: Matrix metalloproteinase-9 participates in NGF-induced alpha-secretase cleavage of amyloid-beta protein precursor in PC12 cells J. Alzheimers Dis. 2011 24: 705-719
21416485 Jayadev S et al.: Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann. Neurol. 2011 69: 712-720
21504563 Piette F et al.: Masitinib as an adjunct therapy for mild-to-moderate Alzheimers disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res Ther 2011 3: 16
21406112 Li B et al.: Stem cell factor and granulocyte colony-stimulating factor reduce beta-amyloid deposits in the brains of APP/PS1 transgenic mice. Alzheimers Res Ther 2011 3: 8
21193043 Barone E et al.: Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action Pharmacol. Res. 2011 63: 172-180
21335656 Perez-Gonzalez R et al.: Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimers disease. J. Alzheimers Dis. 2011 24: 17-25
21633390 Garwood CJ et al.: Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2011 2: E167
21527912 Kumar S et al.: Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimers disease. EMBO J. 2011 30: 2255-2265
21562267 Terwel D et al.: Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis. J. Neurosci. 2011 31: 7049-7059
21817177 Yanagisawa K et al.: [Newly approved drugs for Alzheimer disease: effectiveness and limitation]. Brain Nerve 2011 63: 863-868
19694182 Wang B et al.: Schisandrin B protects rat cortical neurons against Abeta1-42-induced neurotoxicity. Pharmazie 2009 64: 450-454
21037121 Starkstein SE et al.: Anosognosia is a significant predictor of apathy in Alzheimers disease. J Neuropsychiatry Clin Neurosci 2010 22: 378-383
20808100 Orfei MD et al.: Anosognosia in mild cognitive impairment and mild Alzheimers disease: frequency and neuropsychological correlates. Am J Geriatr Psychiatry 2010 18: 1133-1140
20555149 Sedaghat F et al.: Brain SPECT findings of anosognosia in Alzheimers disease. J. Alzheimers Dis. 2010 21: 641-647
20188013 Leicht H et al.: Anosognosia in Alzheimers disease: the role of impairment levels in assessment of insight across domains. J Int Neuropsychol Soc 2010 16: 463-473
17361039 Jacob CP et al.: Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimers disease. J. Alzheimers Dis. 2007 11: 97-116
21211392 Lei JK et al.: [Change of serum ACTH and cortisol levels in Alzheimer disease and mild cognition impairment]. Zhonghua Yi Xue Za Zhi 2010 90: 2894-2896
20937084 Fleisher-Berkovich S et al.: Distinct modulation of microglial amyloid beta phagocytosis and migration by neuropeptides (i). J Neuroinflammation 2010 7: 61
21387370 Himeno E et al.: Apomorphine treatment in Alzheimer mice promoting amyloid-beta degradation. Ann. Neurol. 2011 69: 248-256
21448224 Di Paolo G et al.: Linking lipids to Alzheimers disease: cholesterol and beyond. Nat. Rev. Neurosci. 2011 12: 284-296
21147981 Oliveira TG et al.: Phospholipase d2 ablation ameliorates Alzheimers disease-linked synaptic dysfunction and cognitive deficits. J. Neurosci. 2010 30
21357679 Chapuis J et al.: Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein Hum. Mol. Genet. 2011 20: 2026-2036
19196476 Prinzen C et al.: Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice. BMC Genomics 2009 10: 66
21672962 Rolyan H et al.: Telomere shortening reduces Alzheimers disease amyloid pathology in mice. Brain 2011 134: 2044-2056
21389082 Casas-Tinto S et al.: The ER stress factor XBP1s prevents amyloid-beta neurotoxicity. Hum. Mol. Genet. 2011 20: 2144-2160
18276079 Clement AB et al.: Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Neuroscience 2008 152: 459-468
17722071 Shimmyo Y et al.: Multifunction of myricetin on A beta: neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases. J. Neurosci. Res. 2008 86: 368-377
20592218 Mitterreiter S et al.: Bepridil and amiodarone simultaneously target the Alzheimers disease beta- and gamma-secretase via distinct mechanisms. J. Neurosci. 2010 30: 8974-8983
18391946 Berman DE et al.: Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism Nat. Neurosci. 2008 11: 547-554
19109907 OConnor T et al.: Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 2008 60: 988-1009
20492361 Xu J et al.: Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity J. Neurochem. 2011 116: 192-204
20348102 Lammich S et al.: Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5-untranslated region. J. Biol. Chem. 2010 285
20427278 Ullrich S et al.: The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein. J. Biol. Chem. 2010 285
21955788 Zhang L et al.: Identifying Tmem59 related gene regulatory network of mouse neural stem cell from a compendium of expression profiles. BMC Syst Biol 2011 5: 152
21413990 Lichtenthaler SF et al.: Regulated intramembrane proteolysis--lessons from amyloid precursor protein processing. J. Neurochem. 2011 117: 779-796
21695060 Hogl S et al.: Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and gamma-secretase. PLoS ONE 2011 6
20676056 Kuhn PH et al.: ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 2010 29: 3020-3032
21460840 Hollingworth P et al.: Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimers disease Nat. Genet. 2011 43: 429-435
19879754 Baumann S et al.: NSAID-derived gamma-secretase modulators. Part III: Membrane anchoring. Bioorg. Med. Chem. Lett. 2009 19: 6986-6990
21689411 Ferris SH et al.: Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimers disease. Alzheimers Res Ther 2011 3: 22
19552690 Lu P et al.: Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice Br. J. Pharmacol. 2009 157: 1270-1277
12714508 Hundhausen C et al.: The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion Blood 2003 102: 1186-1195
21881209 Krohn M et al.: Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice J. Clin. Invest. 2011 121: 3924-3931
21035623 Craig-Schapiro R et al.: YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimers disease. Biol. Psychiatry 2010 68: 903-912
16371011 Glatz DC et al.: The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimers disease. J. Neurochem. 2006 96: 635-644
21470964 Qian W et al.: Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. Nucleic Acids Res. 2011 39: 6161-6171
21281635 Jung HJ et al.: Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes. Exp. Neurol. 2011 228: 232-241
21367856 Shi J et al.: Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease. J. Biol. Chem. 2011 286
21807765 Smith PY et al.: MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum. Mol. Genet. 2011 20: 4016-4024
20930824 author information missing article information missing
16943417 Wu JY et al.: SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy. Mol. Cell. Biol. 2006 26: 6739-6747
15972296 Prinzen C et al.: Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J. 2005 19: 1522-1524
19608551 Kim M et al.: Potential late-onset Alzheimers disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum. Mol. Genet. 2009 18: 3987-3996
19498037 Rodriguez-Martin T et al.: Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing Hum. Mol. Genet. 2009 18: 3266-3273
2181826 Godfrey DG et al.: The distribution, relationships and identification of enzymic variants within the subgenus Trypanozoon. Adv. Parasitol. 1990 29: 1-74
16777844 Kar A et al.: RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion. J. Biol. Chem. 2006 281
21333649 Qian W et al.: Splicing factor SC35 promotes tau expression through stabilization of its mRNA. FEBS Lett. 2011 585: 875-880
20615469 Chen KL et al.: Amyloid-beta peptide alteration of tau exon-10 splicing via the GSK3beta-SC35 pathway Neurobiol. Dis. 2010 40: 378-385
19502709 Kooistra J et al.: A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor. J. Alzheimers Dis. 2009 17: 281-294
21365281 Gutierrez-Lopez MD et al.: The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Cell. Mol. Life Sci. 2011 68: 3275-3292
20194618 Ohe K et al.: HMGA1a trapping of U1 snRNP at an authentic 5 splice site induces aberrant exon skipping in sporadic Alzheimers disease. Mol. Cell. Biol. 2010 30: 2220-2228
11193153 Fahrenholz F et al.: Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure. Ann. N. Y. Acad. Sci. 2000 920: 215-222
21799908 Pietrzak M et al.: Epigenetic silencing of nucleolar rRNA genes in Alzheimers disease. PLoS ONE 2011 6
21835916 Wilkinson K et al.: A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36. J. Biol. Chem. 2011 286
15695522 Wang Y et al.: Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1. J. Biol. Chem. 2005 280
22278060 Israel MA et al.: Probing sporadic and familial Alzheimers disease using induced pluripotent stem cells Nature 2012 482: 216-220
15615629 Andreadis A et al.: Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 2005 1739: 91-103
21114897 Radenahmad N et al.: Young coconut juice, a potential therapeutic agent that could significantly reduce some pathologies associated with Alzheimers disease: novel findings. Br. J. Nutr. 2011 105: 738-746
21492498 Barak Y et al.: Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimers disease: a randomized double-blind pilot study Int Psychogeriatr 2011 23: 1515-1519
15890777 Zhou S et al.: CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimers disease amyloid beta-peptide production. Proc. Natl. Acad. Sci. U.S.A. 2005 102: 7499-7504
21343338 Kar A et al.: RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5 splice site. Mol. Cell. Biol. 2011 31: 1812-1821
21902456 Hedskog L et al.: Strategic role for mitochondria in Alzheimers disease and cancer Antioxid. Redox Signal. 2012 16: 1476-1491
21707856 Kato K et al.: Protein kinase C stabilizes X-linked inhibitor of apoptosis protein (XIAP) through phosphorylation at Ser(87) to suppress apoptotic cell death. Psychogeriatrics 2011 11: 90-97
21054783 Hedskog L et al.: gamma-Secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Abeta(42) /Abeta(40) ratio. J. Cell. Mol. Med. 2011 15: 2150-2163
19389700 Quintanilla RA et al.: Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease J. Biol. Chem. 2009 284
22079237 Alldred MJ et al.: Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction Neurobiol. Dis. 2012 45: 751-762
20570249 Yang H et al.: Amelioration of the Alzheimers disease phenotype by absence of 12/15-lipoxygenase Biol. Psychiatry 2010 68: 922-929
21900234 Bate C et al.: Amyloid-beta-induced synapse damage is mediated via cross-linkage of cellular prion proteins. J. Biol. Chem. 2011 286
21715329 Xue Y et al.: Crystal structure of the E2 domain of amyloid precursor protein-like protein 1 in complex with sucrose octasulfate. J. Biol. Chem. 2011 286
22101739 Samy AS et al.: Regulation of IL-1beta-induced cyclooxygenase-2 expression by interactions of Abeta peptide, apolipoprotein E and nitric oxide in human neuroglioma J. Mol. Neurosci. 2012 47: 533-545
21795680 Griffiths HH et al.: Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein. J. Biol. Chem. 2011 286
19671904 Scarmeas N et al.: Physical activity, diet, and risk of Alzheimer disease. JAMA 2009 302: 627-637
20009056 Lieb W et al.: Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009 302: 2565-2572
19887909 Kellett KA et al.: Prion protein and Alzheimer disease. Prion 2009 3: 190-194
20819221 Bitel CL et al.: Increased expression and local accumulation of the prion protein, Alzheimer Abeta peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes. BMC Physiol. 2010 10: 18
22072713 Murakami K et al.: SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease J. Biol. Chem. 2011 286
21694453 Novak P et al.: Tauons and prions: infamous cousins? J. Alzheimers Dis. 2011 26: 413-430
20473510 Reiniger L et al.: Tau, prions and Abeta: the triad of neurodegeneration Acta Neuropathol. 2011 121: 5-20
22100763 Kudo W et al.: Cellular prion protein is essential for oligomeric amyloid-beta-induced neuronal cell death. Hum. Mol. Genet. 2012 21: 1138-1144
22028219 Jucker M et al.: Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 2011 70: 532-540
22017494 Rosen RF et al.: Exogenous seeding of cerebral beta-amyloid deposition in betaAPP-transgenic rats J. Neurochem. 2012 120: 660-666
21699076 Szymanski P et al.: Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimers disease Pharmazie 2011 66: 399-403
20598287 Grimmer T et al.: Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimers disease Biol. Psychiatry 2010 68: 879-884
20400860 Khalifa NB et al.: What is the role of amyloid precursor protein dimerization Cell Adh Migr 2010 4: 268-272
17050537 Kuan YH et al.: PAT1a modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2 J. Biol. Chem. 2006 281
16230627 Rodriguez-Martin T et al.: Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies Proc. Natl. Acad. Sci. U.S.A. 2005 102
22077634 Sheng B et al.: Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimers disease J. Neurochem. 2012 120: 419-429
19273754 Qin W et al.: PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia Arch. Neurol. 2009 66: 352-361
21255795 Zhang Y et al.: The -1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimers disease: a meta-analysis J. Neurol. Sci. 2011 303: 133-138
20479757 Conejero-Goldberg C et al.: Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimers disease as based on APOE genotype Mol. Psychiatry 2011 16: 836-847
17998437 Li H et al.: Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease Arch. Neurol. 2008 65: 45-53
17684015 Huttunen HJ et al.: HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation J. Biol. Chem. 2007 282
18292081 Kotilinek LA et al.: Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity Brain 2008 131: 651-664
19943124 Rothman SM et al.: Adverse stress, hippocampal networks, and Alzheimers disease Neuromolecular Med. 2010 12: 56-70
22275252 Chu J et al.: Transcriptional regulation of beta-secretase-1 by 12/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments Ann. Neurol. 2012 71: 57-67
18021299 Tachida Y et al.: Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production J. Neurochem. 2008 104: 1387-1393
18587388 Yuzwa SA et al.: A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo Nat. Chem. Biol. 2008 4: 483-490
17940659 Dias WB et al.: O-GlcNAc modification in diabetes and Alzheimers disease Mol Biosyst 2007 3: 766-772
19122823 Bajic VP et al.: Is the time dimension of the cell cycle re-entry in AD regulated by centromere cohesion dynamics Biosci Hypotheses 2008 1: 156-161
15974909 Ringman JM et al.: A potential role of the curry spice curcumin in Alzheimers disease Curr Alzheimer Res 2005 2: 131-136
18815129 Ono K et al.: Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity J. Biol. Chem. 2008 283
18032783 Nixon RA et al.: Autophagy, amyloidogenesis and Alzheimer disease J. Cell. Sci. 2007 120: 4081-4091
21968187 Klug W et al.: Phosphorylation of LRP1 regulates the interaction with Fe65 FEBS Lett. 2011 585: 3229-3235
16195917 Mikol J et al.: Extensive cortico-subcortical lesions in Wilsons disease: clinico-pathological study of two cases Acta Neuropathol. 2005 110: 451-458
22264991 Chen R et al.: Elevation of serum TNF-alpha levels in mild and moderate Alzheimer patients with daytime sleepiness J. Neuroimmunol. 2012 244: 97-102
22349686 Spalletta G et al.: Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment J. Alzheimers Dis. 2012 29: 761-772
21129451 Jardanhazi-Kurutz D et al.: Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice Neuroscience 2011 176: 396-407
11470313 Strausak D et al.: Copper in disorders with neurological symptoms: Alzheimers, Menkes, and Wilson diseases Brain Res. Bull. 2001 55: 175-185
20493925 Song H et al.: Association between haplotype -88G/25G in A2M with Alzheimers disease Neurosci. Lett. 2010 479: 143-145
9697696 Blacker D et al.: Alpha-2 macroglobulin is genetically associated with Alzheimer disease Nat. Genet. 1998 19: 357-360
21216965 Chen WT et al.: Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation J. Biol. Chem. 2011 286: 9646-9656
16236446 Deary IJ et al.: Polymorphisms in the gene encoding 11B-hydroxysteroid dehydrogenase type 1 (HSD11B1) and lifetime cognitive change Neurosci. Lett. 2006 393: 74-77
14583441 de Quervain DJ et al.: Glucocorticoid-related genetic susceptibility for Alzheimers disease Hum. Mol. Genet. 2004 13: 47-52
11257240 Rasmuson S et al.: Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimers disease Biol. Psychiatry 2001 49: 547-552
20157240 Souza-Talarico JN et al.: Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimers disease subjects J. Alzheimers Dis. 2010 19: 839-848
22660329 Nussbaum JM et al.: Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta Nature 2012 485: 651-655
22654059 Barrett PJ et al.: The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol Science 2012 336: 1168-1171
18482978 Tolia A et al.: Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase J. Biol. Chem. 2008 283
20871650 Shawkatova I et al.: No association between cytokine gene polymorphism and risk of Alzheimers disease in Slovaks Acta Neurobiol Exp (Wars) 2010 70: 303-307
22178568 Fang M et al.: The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimers disease Toxicol. Lett. 2012 209: 94-105
18096514 Lee MR et al.: Inhibition of APP intracellular domain (AICD) transcriptional activity via covalent conjugation with Nedd8 Biochem. Biophys. Res. Commun. 2008 366: 976-981
22506131 Borquez DA et al.: The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimers disease Int J Alzheimers Dis 2012 2012
19282473 Stante M et al.: Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks Proc. Natl. Acad. Sci. U.S.A. 2009 106: 5093-5098
15331662 von Rotz RC et al.: The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor J. Cell. Sci. 2004 117: 4435-4448
22122663 Pardossi-Piquard R et al.: The physiology of the beta-amyloid precursor protein intracellular domain AICD J. Neurochem. 2012 120: 109-124
17093061 Muller T et al.: Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD) Mol. Biol. Cell 2007 18: 201-210
15708439 Caccamo A et al.: Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders Neurobiol. Aging 2005 26: 645-654
22563077 Maesako M et al.: Exercise Is More Effective than Diet Control in Preventing High Fat Diet-induced beta-Amyloid Deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice J. Biol. Chem. 2012 287
22303443 Westin K et al.: CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimers disease PLoS ONE 2012 7
22805778 Hoshi A et al.: Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease J. Neuropathol. Exp. Neurol. 2012 71: 750-759
22801501 Jonsson T et al.: A mutation in APP protects against Alzheimers disease and age-related cognitive decline Nature 2012 488: 96-99
10742146 Lu DC et al.: A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor Nat. Med. 2000 6: 397-404
14557245 Chen Y et al.: APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimers disease brain J. Cell Biol. 2003 163: 27-33
12533840 Dil Kuazi A et al.: NEDD8 protein is involved in ubiquitinated inclusion bodies J. Pathol. 2003 199: 259-266
18801622 Guldiken S et al.: Subclinical Cushings syndrome is a potential cause of metabolic dementia and rapidly progressive Alzheimer-type dementia Med. Hypotheses 2008 71: 703-705
16125145 Elgh E et al.: Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimers disease Biol. Psychiatry 2006 59: 155-161
10722740 Chen Y et al.: The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons J. Biol. Chem. 2000 275: 8929-8935
21880910 Li X et al.: Neuronal production of transthyretin in human and murine Alzheimers disease: is it protective J. Neurosci. 2011 31
15192323 Chen YZ et al.: APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin Apoptosis 2004 9: 415-422
12777371 Weggen S et al.: Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain J. Biol. Chem. 2003 278
20689579 Ghosal K et al.: APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation PLoS ONE 2010 5
21958873 Paris D et al.: Anatabine lowers Alzheimers Abeta production in vitro and in vivo Eur. J. Pharmacol. 2011 670: 384-391
16973241 Carter CJ et al.: Convergence of genes implicated in Alzheimers disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis Neurochem. Int. 2007 50: 12-38
22464332 Nakamura K et al.: Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimers disease Cell 2012 149: 232-244
18587408 Faghihi MA et al.: Expression of a noncoding RNA is elevated in Alzheimers disease and drives rapid feed-forward regulation of beta-secretase Nat. Med. 2008 14: 723-730
22915175 Singh-Manoux A et al.: Obesity phenotypes in midlife and cognition in early old age: the Whitehall II cohort study Neurology 2012 79: 755-762
22796576 Eyles DW et al.: Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease Front Neuroendocrinol 2013 34: 47-64
22591405 Qiao DL et al.: Is vitamin D beneficial to Alzheimer disease? A surprising dilemma CNS Neurosci Ther 2012 18: 601-603
21486290 Webster SJ et al.: The acute effects of dimebolin, a potential Alzheimers disease treatment, on working memory in rhesus monkeys Br. J. Pharmacol. 2011 164: 970-978
22942647 Sozio P et al.: Transdermal donepezil on the treatment of Alzheimers disease Neuropsychiatr Dis Treat 2012 8: 361-368
21502597 Rafii MS et al.: A phase II trial of huperzine A in mild to moderate Alzheimer disease Neurology 2011 76: 1389-1394
22227962 Kummer MP et al.: Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice J Neuroimmune Pharmacol 2012 7: 165-172
22766135 Martins LC et al.: Disease-specific expression of the serotonin-receptor 5-HT(2C) in natural killer cells in Alzheimers dementia J. Neuroimmunol. 2012 251: 73-79
19072283 Owen JB et al.: Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimers disease and mild cognitive impairment: implications for progression of AD J. Proteome Res. 2009 8: 471-482
22801742 Doecke JD et al.: Blood-based protein biomarkers for diagnosis of Alzheimer disease Arch. Neurol. 2012 69: 1318-1325
22329649 Cai H et al.: Metabolic dysfunction in Alzheimers disease and related neurodegenerative disorders Curr Alzheimer Res 2012 9: 5-17
16843497 Rentzos M et al.: Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimers disease and frontotemporal dementia J. Neurol. Sci. 2006 249: 110-114
23178247 Vom Berg J et al.: Inhibition of IL-12/IL-23 signaling reduces Alzheimers disease-like pathology and cognitive decline Nat. Med. 2012 18: 1812-1819
11137576 Szczepanik AM et al.: IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line J. Neuroimmunol. 2001 113: 49-62
23157339 Arlt S et al.: Genetic risk factors for depression in Alzheimer`s disease patients Curr Alzheimer Res 2013 10: 72-81
22970774 Azizi G et al.: The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis Immunopharmacol Immunotoxicol 2012 34: 881-895
19776284 Reed-Geaghan EG et al.: CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation J. Neurosci. 2009 29
21071836 Murata N et al.: Silymarin attenuated the amyloid beta plaque burden and improved behavioral abnormalities in an Alzheimers disease mouse model Biosci. Biotechnol. Biochem. 2010 74: 2299-2306
21185897 Yin F et al.: Silibinin: a novel inhibitor of Abeta aggregation Neurochem. Int. 2011 58: 399-403
22610069 Lehmann SM et al.: An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration Nat. Neurosci. 2012 15: 827-835
19464758 Srikanth V et al.: Advanced glycation endproducts and their receptor RAGE in Alzheimers disease Neurobiol. Aging 2011 32: 763-777
23393093 Mori K et al.: The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS Science 2013 339: 1335-1338
23352322 Cacace R et al.: C9orf72 G4C2 repeat expansions in Alzheimers disease and mild cognitive impairment Neurobiol. Aging 2013 34: 1712
23150934 Guerreiro R et al.: TREM2 variants in Alzheimers disease N. Engl. J. Med. 2013 368: 117-127
19484711 Oulhaj A et al.: Homocysteine as a predictor of cognitive decline in Alzheimers disease Int J Geriatr Psychiatry 2010 25: 82-90
9823829 Clarke R et al.: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease Arch. Neurol. 1998 55: 1449-1455
22964832 Xi Z et al.: Investigation of c9orf72 in 4 neurodegenerative disorders Arch. Neurol. 2012 69: 1583-1590
16688597 Rota E et al.: Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimers disease patients Neurol. Sci. 2006 27: 33-39
9147373 Xu S et al.: Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimers disease Mech. Ageing Dev. 1997 94: 213-222
21857683 Deng HX et al.: Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia Nature 2011 477: 211-215
20074050 Haapasalo A et al.: Emerging role of Alzheimers disease-associated ubiquilin-1 in protein aggregation Biochem. Soc. Trans. 2010 38: 150-155
21966562 Haapasalo A et al.: Involvement of ubiquilin-1 transcript variants in protein degradation and accumulation Commun Integr Biol 2011 4: 428-432
23162743 Ma QL et al.: PAK in Alzheimer disease, Huntington disease and X-linked mental retardation Cell Logist 2012 2: 117-125
21852239 Stieren ES et al.: Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein J. Biol. Chem. 2011 286
23204143 Yarchoan M et al.: Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias Brain 2012 135: 3749-3756
22745485 Kook SY et al.: Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling J. Neurosci. 2012 32: 8845-8854
23208281 Ashe KH et al.: Prions, prionoids and pathogenic proteins in Alzheimer disease Prion 2013 7: 55-59
21969301 Bakalash S et al.: Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimers disease Invest. Ophthalmol. Vis. Sci. 2011 52: 9033-9046
23667698 Takasugi N et al.: FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-beta Production in Neurons PLoS ONE 2013 8
15923191 Tamboli IY et al.: Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide J. Biol. Chem. 2005 280
20110603 Rojo LE et al.: Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimers disease J. Alzheimers Dis. 2010 19: 573-589
10226937 Baran H et al.: Kynurenine metabolism in Alzheimers disease J Neural Transm 1999 106: 165-181
17017544 Nemeth H et al.: Kynurenines, Parkinsons disease and other neurodegenerative disorders: preclinical and clinical studies J. Neural Transm. Suppl. 2006 70: 285-304
21538537 De Deyn PP et al.: Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimers disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study Int J Geriatr Psychiatry 2012 27: 296-304
15465626 Walter A et al.: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients Neurobiol. Aging 2004 25: 1299-1303
16227558 Serot JM et al.: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimers disease J. Neurol. Neurosurg. Psychiatr. 2005 76: 1585-1587
23365075 Browne TC et al.: IFN-gamma Production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimers disease J. Immunol. 2013 190: 2241-2251
19199127 Leoni V et al.: Oxysterols as markers of neurological disease--a review Scand. J. Clin. Lab. Invest. 2009 69: 22-25
11027840 Bretillon L et al.: Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases Neurosci. Lett. 2000 293: 87-90
23666171 Leoni V et al.: Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health J. Alzheimers Dis. 2013 36: 739-747
23285020 Hosokawa M et al.: Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice PLoS ONE 2012 7
23435411 Lira-De Leon KI et al.: Molecular mechanism of tau aggregation induced by anionic and cationic dyes J. Alzheimers Dis. 2013 35: 319-334
23443659 Crowe A et al.: Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation J. Biol. Chem. 2013 288
23653592 Xie L et al.: Methylene blue induces macroautophagy through 5 adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation Front Cell Neurosci 2013 7: 56
22377780 Hughes TM et al.: Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimers disease J. Alzheimers Dis. 2012 30: 53-61
20158567 Nilsson P et al.: Gene therapy in Alzheimers disease - potential for disease modification J. Cell. Mol. Med. 2010 14: 741-757
21383512 Mori K et al.: Effects of Hericium erinaceus on amyloid beta(25-35) peptide-induced learning and memory deficits in mice Biomed. Res. 2011 32: 67-72
18758067 Mori K et al.: Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells Biol. Pharm. Bull. 2008 31: 1727-1732
22078238 Costa A et al.: Galanin and alpha-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimers disease J. Neuroimmunol. 2011 240-241: 114-120
21399480 Lauterbach EC et al.: Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease Alzheimer Dis Assoc Disord 2012 26: 1-7
23935582 Mariani S et al.: Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimers and Parkinsons diseases Front Aging Neurosci 2013 5: 37
17234346 Salins P et al.: Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling Neurosci. Lett. 2007 412: 211-216
22654722 Heneka MT et al.: Impact and Therapeutic Potential of PPARs in Alzheimers Disease Curr Neuropharmacol 2011 9: 643-650
10078972 Pradier L et al.: Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction Neurobiol. Dis. 1999 6: 43-55
24270855 Han J et al.: OCIAD2 activates gamma-secretase to enhance amyloid beta production by interacting with nicastrin Cell. Mol. Life Sci. 2014 71: 2561-2576
11740561 Kamal A et al.: Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP Nature 2001 414: 643-648
21298039 Gatta V et al.: Microarray analysis on human neuroblastoma cells exposed to aluminum, beta(1-42)-amyloid or the beta(1-42)-amyloid aluminum complex PLoS ONE 2011 6
24780254 Laurent C et al.: Beneficial effects of caffeine in a transgenic model of Alzheimers disease-like tau pathology Neurobiol. Aging 2014 35: 2079-2090
11278378 Kihara T et al.: alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity J. Biol. Chem. 2001 276
10681545 Wang HY et al.: beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimers disease pathology J. Biol. Chem. 2000 275: 5626-5632
24123152 Zhang L et al.: Tyrosine phosphatase STEP61 negatively regulates amyloid beta-mediated ERK/CREB signaling pathways via alpha7 nicotinic acetylcholine receptors J. Neurosci. Res. 2013 91: 1581-1590
23810791 Sokolov AN et al.: Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior Neurosci Biobehav Rev 2013 37: 2445-2453
21982844 Williams RJ et al.: Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease Free Radic. Biol. Med. 2012 52: 35-45
24511465 Robin NC et al.: Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/beta-Catenin Signaling Stem Cell Reports 2013 2: 9-17
16230462 Ryan KA et al.: Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain J. Cell Biol. 2005 171: 327-335
18070361 Chen Y et al.: Amyloid precursor protein modulates beta-catenin degradation J Neuroinflammation 2007 4: 29
18234671 Magdesian MH et al.: Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling J. Biol. Chem. 2008 283: 9359-9368
25878270 Kan MJ et al.: Arginine deprivation and immune suppression in a mouse model of Alzheimers disease J. Neurosci. 2015 15: 5969-5982
25502766 Sun Y et al.: Translational study of Alzheimers disease (AD) biomarkers from brain tissues in AbetaPP/PS1 mice and serum of AD patients J. Alzheimers Dis. 2015 45: 269-282
22406198 Kim YH et al.: Proteomic analysis of plasma from a Tau transgenic mouse Int. J. Dev. Neurosci. 2012 30: 277-283
21912965 Boda E et al.: Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimers disease J. Mol. Neurosci. 2012 3: 606-615
15485486 Angulo E et al.: Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimers disease J. Neurochem. 2004 3: 547-557
18449908 Poduslo SE et al.: Genome screen of late-onset Alzheimers extended pedigrees identifies TRPC4AP by haplotype analysis Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009 1: 50-55
21116278 Furney SJ et al.: Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimers disease Mol. Psychiatry 2011 16: 1130-1138
26458046 Mainz A et al.: The chaperone alphaB-crystallin uses different interfaces to capture an amorphous and an amyloid client
26033219 Cecarini V et al.: Effects of Ghrelin on the Proteolytic Pathways of Alzheimers Disease Neuronal Cells
25998028 Folch J et al.: The role of leptin in the sporadic form of Alzheimers disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin Life Sci. 2015 140: 19-28
23595620 Hokama M et al.: Altered expression of diabetes-related genes in Alzheimers disease brains: the Hisayama study Cereb. Cortex 2014 24: 2476-2488
26515689 Lin CL et al.: Amyloid-beta suppresses AMP-activated protein kinase (AMPK) signaling and contributes to alpha-synuclein-induced cytotoxicity Exp. Neurol. 2016 275: 84-98
22367557 Cai Z et al.: Roles of AMP-activated protein kinase in Alzheimers disease Neuromolecular Med. 2012 14: 1-14
26250687 Goedert M et al.: NEURODEGENERATION. Alzheimers and Parkinsons diseases: The prion concept in relation to assembled Abeta, tau, and alpha-synuclein Science 2015 349
22746245 Nunes MA et al.: Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimers disease Curr Alzheimer Res 2013 10: 104-107
23246577 Lee E et al.: Effect of conjugated linoleic acid, mu-calpain inhibitor, on pathogenesis of Alzheimers disease Biochim. Biophys. Acta 2013 1831: 709-718
9848094 Torp R et al.: GADD45 is induced in Alzheimers disease, and protects against apoptosis in vitro Neurobiol. Dis. 1998 5: 245-252
19176370 Catalano A et al.: The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells. Cancer Res. 2009 69: 1485-1493
19176370 Catalano A et al.: The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells Cancer Res. 2009 69: 1485-1493
19325129 Schwarz Q et al.: Neuropilin 1 signaling guides neural crest cells to coordinate pathway choice with cell specification. Proc. Natl. Acad. Sci. U.S.A. 2009 106: 6164-6169
9331345 Taniguchi M et al.: Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection Neuron 1997 19: 519-530
18708346 Bae D et al.: Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. J. Biol. Chem. 2008 283
18664627 Kawamura H et al.: Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 2008 112: 3638-3649
16966330 Lamalice L et al.: Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF. J. Biol. Chem. 2006 281
14724572 Lamalice L et al.: Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 2004 23: 434-445
17569671 Guttmann-Raviv N et al.: Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem. 2007 282
18056484 Moretti S et al.: Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. Blood 2008 111: 2290-2299
9215629 Yang X et al.: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997 89: 1067-1076
16330548 Kurschat P et al.: Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J. Biol. Chem. 2006 281: 2721-2729
17369826 Semenova MM et al.: Rho mediates calcium-dependent activation of p38alpha and subsequent excitotoxic cell death. Nat. Neurosci. 2007 10: 436-443
19251628 Vance C et al.: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009 323: 1208-1211
18309045 Sreedharan J et al.: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008 319: 1668-1672
17023659 Neumann M et al.: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006 314: 130-133
17469116 Mackenzie IR et al.: Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations Ann. Neurol. 2007 61: 427-434
8446170 Rosen DR et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993 362: 59-62
10196546 Takahashi T et al.: Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors. Nat. Neurosci. 1998 1: 487-493
10520994 Takahashi T et al.: Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999 99: 59-69
16495486 Chadborn NH et al.: PTEN couples Sema3A signalling to growth cone collapse. J. Cell. Sci. 2006 119: 951-957
11956225 Eickholt BJ et al.: An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J. Cell Biol. 2002 157: 211-217
18180379 Acevedo LM et al.: Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 2008 111: 2674-2680
18327764 Gallo G et al.: Semaphorin 3A inhibits ERM protein phosphorylation in growth cone filopodia through inactivation of PI3K. Dev Neurobiol 2008 68: 926-933
9236236 Jin Z et al.: Rac1 mediates collapsin-1-induced growth cone collapse. J. Neurosci. 1997 17: 6256-6263
18272814 Narazaki M et al.: Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A Blood 2008 111: 4126-4136
15378658 Weydt P et al.: Increased cytotoxic potential of microglia from ALS-transgenic mice Glia 2004 48: 179-182
19672969 Zhao W et al.: Extracellular mutant SOD1 induces microglial-mediated motoneuron injury Glia 2010 58: 231-243
18519638 Nishitoh H et al.: ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1 Genes Dev. 2008 22: 1451-1464
12847526 Lambrechts D et al.: VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003 34: 383-394
11381259 Oosthuyse B et al.: Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001 28: 131-138
18519638 Nishitoh H et al.: ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1 Genes Dev. 2008 22: 1451-1464
19762508 Hetz C et al.: XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy Genes Dev. 2009 23: 2294-2306
19762508 Hetz C et al.: XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009 23: 2294-2306
15568021 Storkebaum E et al.: Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 2005 8: 85-92
19183264 Suzuki H et al.: ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB J. Neurochem. 2009 108: 973-985
18233996 Oh YK et al.: Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells J. Neurochem. 2008 104: 993-1005
19330001 Saxena S et al.: A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice Nat. Neurosci. 2009 12: 627-636
19330001 Saxena S et al.: A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009 12: 627-636
18077368 Kieran D et al.: Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proc. Natl. Acad. Sci. U.S.A. 2007 104
18077368 Kieran D et al.: Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice Proc. Natl. Acad. Sci. U.S.A. 2007 104
18413601 Taoufik E et al.: TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc. Natl. Acad. Sci. U.S.A. 2008 105: 6185-6190
7507336 Cheng B et al.: Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis Neuron 1994 12: 139-153
11029549 Jin KL et al.: Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience 2000 99: 577-585
16847061 Atkin JD et al.: Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1 J. Biol. Chem. 2006 281
16847061 Atkin JD et al.: Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1 J. Biol. Chem. 2006 281
16847061 Atkin JD et al.: Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J. Biol. Chem. 2006 281
19661182 Ying Z et al.: Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum. Mol. Genet. 2009 18: 4268-4281
19661182 Ying Z et al.: Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation Hum. Mol. Genet. 2009 18: 4268-4281
9618543 Rosenstein JM et al.: Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 1998 95: 7086-7091
19661182 Ying Z et al.: Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation Hum. Mol. Genet. 2009 18: 4268-4281
9618543 Rosenstein JM et al.: Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 1998 95: 7086-7091
18566591 Jeyabalan A et al.: Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am. J. Hypertens. 2008 21: 943-947
19889996 Yang YS et al.: Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis. J. Neurosci. 2009 29
17360578 Warner-Schmidt JL et al.: VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl. Acad. Sci. U.S.A. 2007 104: 4647-4652
18263603 Gkogkas C et al.: VAPB interacts with and modulates the activity of ATF6 Hum. Mol. Genet. 2008 17: 1517-1526
18263603 Gkogkas C et al.: VAPB interacts with and modulates the activity of ATF6 Hum. Mol. Genet. 2008 17: 1517-1526
16891305 Kanekura K et al.: Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8) J. Biol. Chem. 2006 281
16192378 McCloskey DP et al.: Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures J. Neurosci. 2005 25: 8889-8897
19109488 Kieran D et al.: Control of motoneuron survival by angiogenin J. Neurosci. 2008 28
19109488 Kieran D et al.: Control of motoneuron survival by angiogenin J. Neurosci. 2008 28
18065154 Nicoletti JN et al.: Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus. Neuroscience 2008 151: 232-241
19444281 Sebastia J et al.: Angiogenin protects motoneurons against hypoxic injury. Cell Death Differ. 2009 16: 1238-1247
19444281 Sebastia J et al.: Angiogenin protects motoneurons against hypoxic injury Cell Death Differ. 2009 16: 1238-1247
19444281 Sebastia J et al.: Angiogenin protects motoneurons against hypoxic injury Cell Death Differ. 2009 16: 1238-1247
15258583 Cao L et al.: VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 2004 36: 827-835
16581901 Raoul C et al.: Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL Proc. Natl. Acad. Sci. U.S.A. 2006 103: 6007-6012
15258583 Cao L et al.: VEGF links hippocampal activity with neurogenesis, learning and memory Nat. Genet. 2004 36: 827-835
16964394 Yoshino Y et al.: Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int. J. Oncol. 2006 29: 981-987
12354397 Raoul C et al.: Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 2002 35: 1067-1083
15207859 Ackerley S et al.: p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis Mol. Cell. Neurosci. 2004 26: 354-364
15207859 Ackerley S et al.: p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 2004 26: 354-364
15207859 Ackerley S et al.: p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis Mol. Cell. Neurosci. 2004 26: 354-364
16000635 Martin LJ et al.: Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation J. Neurosci. 2005 25: 6449-6459
16000635 Martin LJ et al.: Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation J. Neurosci. 2005 25: 6449-6459
12812752 Tortarolo M et al.: Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression Mol. Cell. Neurosci. 2003 23: 180-192
17630988 Petri S et al.: The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis J. Neurochem. 2007 102: 991-1000
19091752 Liu Y et al.: Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2 J. Biol. Chem. 2009 284: 3691-3699
16510725 Kiaei M et al.: Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis J. Neurosci. 2006 26: 2467-2473
16510725 Kiaei M et al.: Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2006 26: 2467-2473
19734218 D'Ambrosi N et al.: The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis J. Immunol. 2009 183: 4648-4656
16512913 Yiangou Y et al.: COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 2006 6: 12
16619237 Almer G et al.: Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis Ann. Neurol. 2006 59: 980-983
19477238 Mir M et al.: Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants Neuroscience 2009 162: 959-971
18219391 Harraz MM et al.: SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model J. Clin. Invest. 2008 118: 659-670
18219391 Harraz MM et al.: SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model J. Clin. Invest. 2008 118: 659-670
17853944 Marden JJ et al.: Redox modifier genes in amyotrophic lateral sclerosis in mice J. Clin. Invest. 2007 117: 2913-2919
17389365 Son M et al.: Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology Proc. Natl. Acad. Sci. U.S.A. 2007 104: 6072-6077
19765191 Gal J et al.: Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism J. Neurochem. 2009 111: 1062-1073
19765191 Gal J et al.: Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism J. Neurochem. 2009 111: 1062-1073
19793721 Ferguson CJ et al.: Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. Hum. Mol. Genet. 2009 18: 4868-4878
19793721 Ferguson CJ et al.: Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2 Hum. Mol. Genet. 2009 18: 4868-4878
19944744 Wang X et al.: Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system Neurosci. Lett. 2010 469: 112-116
18250315 Fornai F et al.: Lithium delays progression of amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. U.S.A. 2008 105: 2052-2057
18250315 Fornai F et al.: Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2008 105: 2052-2057
18337307 Proescher JB et al.: Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS Hum. Mol. Genet. 2008 17: 1728-1737
19656261 Tokuda E et al.: Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis J. Neurochem. 2009 111: 181-191
19765193 Boylan K et al.: Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker J. Neurochem. 2009 111: 1182-1191
19765193 Boylan K et al.: Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J. Neurochem. 2009 111: 1182-1191
18003833 Yamashita N et al.: Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1. J. Neurosci. 2007 27
14762105 Shea TB et al.: Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons J. Cell. Sci. 2004 117: 933-941
18519042 Manser C et al.: Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport. FEBS Lett. 2008 582: 2303-2308
18519042 Manser C et al.: Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport FEBS Lett. 2008 582: 2303-2308
19717447 Zhu X et al.: MSC p43 required for axonal development in motor neurons. Proc. Natl. Acad. Sci. U.S.A. 2009 106
10893265 Ackerley S et al.: Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol. 2000 150: 165-176
11082065 El-Husseini AE et al.: PSD-95 involvement in maturation of excitatory synapses. Science 2000 290: 1364-1368
17344389 Su KY et al.: Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. J. Neurosci. 2007 27: 2513-2524
15372378 Nishimura AL et al.: A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004 75: 822-831
20008544 Fasana E et al.: A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum FASEB J. 2010 24: 1419-1430
16945901 Ferri A et al.: Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials Proc. Natl. Acad. Sci. U.S.A. 2006 103
9853749 Migaud M et al.: Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 1998 396: 433-439
19344252 Cozzolino M et al.: Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxid. Redox Signal. 2009 11: 1547-1558
20007902 Williams AH et al.: MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009 326: 1549-1554
18715867 Kawamata H et al.: Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria. J. Biol. Chem. 2008 283
18715867 Kawamata H et al.: Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria J. Biol. Chem. 2008 283
17099709 Kaneko S et al.: A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med. 2006 12: 1380-1389
16478527 Damiano M et al.: Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice J. Neurochem. 2006 96: 1349-1361
9705358 Giraudo E et al.: Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem. 1998 273
12649282 Duval M et al.: Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells. J. Biol. Chem. 2003 278
19041930 Tolosa L et al.: Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition. Neuroscience 2009 158: 1348-1355
18182045 Tolosa L et al.: Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J. Neurochem. 2008 105: 1080-1090
15233914 Pasinelli P et al.: Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 2004 43: 19-30
17855507 Duval M et al.: Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol. Biol. Cell 2007 18: 4659-4668
15233914 Pasinelli P et al.: Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria Neuron 2004 43: 19-30
16710367 Crosio C et al.: Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis Cell Death Differ. 2006 13: 2150-2153
16710367 Crosio C et al.: Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis Cell Death Differ. 2006 13: 2150-2153
19545440 Jaiswal MK et al.: Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci 2009 10: 64
16928866 Gould TW et al.: Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 2006 26: 8774-8786
19046404 Soo KY et al.: Recruitment of mitochondria into apoptotic signaling correlates with the presence of inclusions formed by amyotrophic lateral sclerosis-associated SOD1 mutations J. Neurochem. 2009 108: 578-590
17394546 Ezzi SA et al.: Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation J. Neurochem. 2007 102: 170-178
17394546 Ezzi SA et al.: Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation J. Neurochem. 2007 102: 170-178
17394546 Ezzi SA et al.: Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 2007 102: 170-178
19638399 Kupershmidt L et al.: Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis FASEB J. 2009 23: 3766-3779
19523650 Fang L et al.: Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J. Neurol. Sci. 2009 285: 62-66
17362932 Kiaei M et al.: Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis Exp. Neurol. 2007 205: 74-81
20097566 Soon CP et al.: Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice Neuromuscul. Disord. 2010 20: 260-266
15358145 Choi JS et al.: Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes Biochem. Biophys. Res. Commun. 2004 321: 574-583
15358145 Choi JS et al.: Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes Biochem. Biophys. Res. Commun. 2004 321: 574-583
15198682 Urushitani M et al.: CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70 J. Neurochem. 2004 90: 231-244
19610091 Sone J et al.: Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis J. Neurosci. Res. 2010 88: 123-135
15201339 Nguyen DT et al.: Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress Mol. Biol. Cell 2004 15: 4248-4260
15201339 Nguyen DT et al.: Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress. Mol. Biol. Cell 2004 15: 4248-4260
12145308 Niwa J et al.: Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity J. Biol. Chem. 2002 277
12145308 Niwa J et al.: Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J. Biol. Chem. 2002 277
17666395 Niwa J et al.: Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J. Biol. Chem. 2007 282
14684739 Miyazaki K et al.: NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1 J. Biol. Chem. 2004 279
14684739 Miyazaki K et al.: NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J. Biol. Chem. 2004 279
19179380 Lee J et al.: Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis FASEB J. 2009 23: 1739-1749
17925878 Yamagishi S et al.: An in vitro model for Lewy body-like hyaline inclusion/astrocytic hyaline inclusion: induction by ER stress with an ALS-linked SOD1 mutation PLoS ONE 2007 2: E1030
0 author information missing article information missing
20223753 Wong M et al.: Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice Hum. Mol. Genet. 2010 19: 2284-2302
18706911 Pierce A et al.: GAPDH is conformationally and functionally altered in association with oxidative stress in mouse models of amyotrophic lateral sclerosis J. Mol. Biol. 2008 382: 1195-1210
16043017 Poon HF et al.: Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis Free Radic. Biol. Med. 2005 39: 453-462
17584954 Muller FL et al.: Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 293
17584954 Muller FL et al.: Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 293
20007371 Gros-Louis F et al.: Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2009 106
20007371 Gros-Louis F et al.: Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. U.S.A. 2009 106
20198480 Kraemer BC et al.: Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010 119: 409-419
19379745 Feiguin F et al.: Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009 583: 1586-1592
19816510 Wang M et al.: Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis Cell Death Differ. 2010 17: 488-498
20188146 Tudor EL et al.: Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology Neuroscience 2010 167: 774-785
16835242 Latreille M et al.: Nck in a complex containing the catalytic subunit of protein phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling and cell survival to endoplasmic reticulum stress J. Biol. Chem. 2006 281
16835242 Latreille M et al.: Nck in a complex containing the catalytic subunit of protein phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling and cell survival to endoplasmic reticulum stress J. Biol. Chem. 2006 281
16835242 Latreille M et al.: Nck in a complex containing the catalytic subunit of protein phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling and cell survival to endoplasmic reticulum stress. J. Biol. Chem. 2006 281
19383787 Zhang YJ et al.: Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U.S.A. 2009 106: 7607-7612
19805353 Iwawaki T et al.: Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability. Proc. Natl. Acad. Sci. U.S.A. 2009 106
20379728 Braak H et al.: Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord Acta Neuropathol. 2010 120: 67-74
20043239 Shiina Y et al.: TDP-43 dimerizes in human cells in culture Cell. Mol. Neurobiol. 2010 30: 641-652
20071528 Barmada SJ et al.: Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis J. Neurosci. 2010 30: 639-649
19251627 Kwiatkowski TJ Jr et al.: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009 323: 1205-1208
18923022 Poesen K et al.: Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J. Neurosci. 2008 28
18923022 Poesen K et al.: Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration J. Neurosci. 2008 28
18923022 Poesen K et al.: Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration J. Neurosci. 2008 28
17652584 Lu L et al.: Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression J. Neurosci. 2007 27: 7929-7938
17652584 Lu L et al.: Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J. Neurosci. 2007 27: 7929-7938
19196430 Li X et al.: Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3-untranslated region. J. Neurochem. 2009 108: 1032-1044
19622636 Uemura A et al.: Unconventional splicing of XBP1 mRNA occurs in the cytoplasm during the mammalian unfolded protein response. J. Cell. Sci. 2009 122: 2877-2886
17403682 Zhang F et al.: Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J. Biol. Chem. 2007 282
17403682 Zhang F et al.: Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex J. Biol. Chem. 2007 282
18515363 Strom AL et al.: Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation J. Biol. Chem. 2008 283
18719118 Ilieva HS et al.: Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death Proc. Natl. Acad. Sci. U.S.A. 2008 105
18719118 Ilieva HS et al.: Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death Proc. Natl. Acad. Sci. U.S.A. 2008 105
18178312 Gomes E et al.: p38 MAPK as a negative regulator of VEGF/VEGFR2 signaling pathway in serum deprived human SK-N-SH neuroblastoma cells Neurosci. Lett. 2008 431: 95-100
11445557 Chen R et al.: Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 2001 276
20020442 Price J et al.: Akt-1 mediates survival of chondrocytes from endoplasmic reticulum-induced stress. J. Cell. Physiol. 2010 222: 502-508
15911875 Kieran D et al.: A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice J. Cell Biol. 2005 169: 561-567
12730604 Hafezparast M et al.: Mutations in dynein link motor neuron degeneration to defects in retrograde transport Science 2003 300: 808-812
20428114 Maruyama H et al.: Mutations of optineurin in amyotrophic lateral sclerosis Nature 2010 465: 223-226
20428114 Maruyama H et al.: Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010 465: 223-226
19657041 Perlson E et al.: A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration J. Neurosci. 2009 29: 9903-9917
15339911 Hu P et al.: Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J. Biol. Chem. 2004 279
12654515 Li B et al.: VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res. Mol. Brain Res. 2003 111: 155-164
17991856 Lin JH et al.: IRE1 signaling affects cell fate during the unfolded protein response. Science 2007 318: 944-949
18305234 Laird FM et al.: Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking J. Neurosci. 2008 28: 1997-2005
18094236 Lai C et al.: The G59S mutation in p150(glued) causes dysfunction of dynactin in mice J. Neurosci. 2007 27
18701194 Anagnostou G et al.: Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging 2010 31: 969-985
18555774 Tsuda H et al.: The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell 2008 133: 963-977
18344992 Zhong Z et al.: ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration Nat. Neurosci. 2008 11: 420-422
18030339 Garbuzova-Davis S et al.: Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS PLoS ONE 2007 2: E1205
19841542 Zhong Z et al.: Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells J. Clin. Invest. 2009 119: 3437-3449
19841542 Zhong Z et al.: Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells J. Clin. Invest. 2009 119: 3437-3449
16236328 Shao L et al.: Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci. 2006 78: 1317-1323
15980862 Ravikumar B et al.: Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 2005 37: 771-776
14960605 Nguyen MD et al.: Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis J. Neurosci. 2004 24: 1340-1349
15056289 Pehar M et al.: Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis J. Neurochem. 2004 89: 464-473
20138122 Milane A et al.: P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis Neurosci. Lett. 2010 472: 166-170
11754077 Cassina P et al.: Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis J. Neurosci. Res. 2002 67: 21-29
19733563 Neymotin A et al.: Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis Exp. Neurol. 2009 220: 191-197
20616880 Huang C et al.: Sustained expression of TDP-43 and FUS in motor neurons in rodents lifetime Int. J. Biol. Sci. 2010 6: 396-406
20606625 Dormann D et al.: ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import EMBO J. 2010 29: 2841-2857
20606625 Dormann D et al.: ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import EMBO J. 2010 29: 2841-2857
17481916 Strong MJ et al.: TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein Mol. Cell. Neurosci. 2007 35: 320-327
17481916 Strong MJ et al.: TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein Mol. Cell. Neurosci. 2007 35: 320-327
20517935 Deng HX et al.: FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis Ann. Neurol. 2010 67: 739-748
18305110 Winton MJ et al.: Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation J. Biol. Chem. 2008 283
20570967 Crippa V et al.: The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS) Hum. Mol. Genet. 2010 19: 3440-3456
20570967 Crippa V et al.: The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS) Hum. Mol. Genet. 2010 19: 3440-3456
20624952 Ling SC et al.: ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS Proc. Natl. Acad. Sci. U.S.A. 2010 107
19815002 Volkening K et al.: Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) Brain Res. 2009 1305: 168-182
20138212 Caragounis A et al.: Zinc induces depletion and aggregation of endogenous TDP-43 Free Radic. Biol. Med. 2010 48: 1152-1161
16877542 Wu DC et al.: The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice Proc. Natl. Acad. Sci. U.S.A. 2006 103
20219021 Rentzos M et al.: Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation Acta Neurol. Scand. 2010 122: 425-429
19752764 Sargsyan SA et al.: Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1 Neuroreport 2009 20: 1450-1455
17852013 Rentzos M et al.: RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis Amyotroph Lateral Scler 2007 8: 283-287
18997009 Chiu IM et al.: T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS Proc. Natl. Acad. Sci. U.S.A. 2008 105
20071543 Duplan L et al.: Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death J. Neurosci. 2010 30: 785-796
20071543 Duplan L et al.: Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death J. Neurosci. 2010 30: 785-796
19323997 Yang Y et al.: Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1 Neuron 2009 61: 880-894
19323997 Yang Y et al.: Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1 Neuron 2009 61: 880-894
11818550 Howland DS et al.: Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc. Natl. Acad. Sci. U.S.A. 2002 99: 1604-1609
19074031 Vargas MR et al.: Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis J. Neurosci. 2008 28
14755726 Henkel JS et al.: Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue Ann. Neurol. 2004 55: 221-235
19429692 D'Ambrogio A et al.: Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo Nucleic Acids Res. 2009 37: 4116-4126
19910924 Fiesel FC et al.: Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6 EMBO J. 2010 29: 209-221
19910924 Fiesel FC et al.: Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6 EMBO J. 2010 29: 209-221
20361056 Zhou H et al.: Transgenic rat model of neurodegeneration caused by mutation in the TDP gene PLoS Genet. 2010 6
17555556 Xiao Q et al.: Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia J. Neurochem. 2007 102: 2008-2019
19888600 Chen K et al.: Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice Brain Struct Funct 2010 214: 219-234
19236470 Kuhle J et al.: Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis Eur. J. Neurol. 2009 16: 771-774
19236470 Kuhle J et al.: Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis Eur. J. Neurol. 2009 16: 771-774
19005069 Cheret C et al.: Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J. Neurosci. 2008 28
18598679 Li B et al.: The NADPH oxidase is involved in lipopolysaccharide-mediated motor neuron injury. Brain Res. 2008 1226: 199-208
19307024 Mantovani S et al.: Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process J. Neuroimmunol. 2009 210: 73-79
20544912 Mitchell RM et al.: Plasma biomarkers associated with ALS and their relationship to iron homeostasis Muscle Nerve 2010 42: 95-103
18825663 Liang X et al.: The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis Ann. Neurol. 2008 64: 304-314
18825663 Liang X et al.: The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis Ann. Neurol. 2008 64: 304-314
19539030 Casafont I et al.: TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons J. Struct. Biol. 2009 167: 235-241
20740007 Elden AC et al.: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS Nature 2010 466: 1069-1075
20579074 Huang EJ et al.: Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions Brain Pathol. 2010 20: 1069-1076
20544928 Rademakers R et al.: Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis Muscle Nerve 2010 42: 170-176
20154090 Hanson KA et al.: Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS) J. Biol. Chem. 2010 285
19112176 Kim SH et al.: Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1 J. Biol. Chem. 2009 284: 8083-8092
19887443 Nishimoto Y et al.: Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J. Biol. Chem. 2010 285: 608-619
17898224 Zhang YJ et al.: Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43 J. Neurosci. 2007 27
20600671 Duan W et al.: Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell Neuroscience 2010 169: 1621-1629
20133711 Wils H et al.: TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration Proc. Natl. Acad. Sci. U.S.A. 2010 107: 3858-3863
18546284 Hasegawa M et al.: Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Ann. Neurol. 2008 64: 60-70
18546284 Hasegawa M et al.: Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Ann. Neurol. 2008 64: 60-70
20303959 Guo Y et al.: Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice FEBS Lett. 2010 584: 1615-1622
19223871 Tatom JB et al.: Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrigs disease in rats via TDP-43 overexpression Mol. Ther. 2009 17: 607-613
19833869 Wegorzewska I et al.: TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration Proc. Natl. Acad. Sci. U.S.A. 2009 106
20660762 Chiang PM et al.: Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism Proc. Natl. Acad. Sci. U.S.A. 2010 107
16369483 Urushitani M et al.: Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis Nat. Neurosci. 2006 9: 108-118
16369483 Urushitani M et al.: Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis Nat. Neurosci. 2006 9: 108-118
20829229 Ferri A et al.: Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity Hum. Mol. Genet. 2010 19: 4529-4542
20202083 Yamashita S et al.: DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity J. Neurochem. 2010 113: 860-870
20202083 Yamashita S et al.: DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity J. Neurochem. 2010 113: 860-870
19889637 Zhou J et al.: Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis J. Biol. Chem. 2010 285: 705-712
20460269 Pedrini S et al.: ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2 Hum. Mol. Genet. 2010 19: 2974-2986
20460269 Pedrini S et al.: ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2 Hum. Mol. Genet. 2010 19: 2974-2986
17510659 Hetz C et al.: The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis Cell Death Differ. 2007 14: 1386-1389
17510659 Hetz C et al.: The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis Cell Death Differ. 2007 14: 1386-1389
19100675 Abutin RM et al.: Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells Exp. Hematol. 2009 37: 151-158
20456006 Tovar-Y-Romo LB et al.: VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK J. Neurochem. 2010 115: 1090-1101
19741096 Yonashiro R et al.: Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation Mol. Biol. Cell 2009 20: 4524-4530
10650002 Urano F et al.: Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1 Science 2000 287: 664-666
17178835 Jiang SX et al.: Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo Mol. Cell. Biol. 2007 27: 1696-1705
20890041 Reyes NA et al.: Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis J. Clin. Invest. 2010 120: 3673-3679
18160256 Nawa M et al.: A novel Akt/PKB-interacting protein promotes cell adhesion and inhibits familial amyotrophic lateral sclerosis-linked mutant SOD1-induced neuronal death via inhibition of PP2A-mediated dephosphorylation of Akt/PKB Cell. Signal. 2008 20: 493-505
18086918 Kang J et al.: MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis J. Cell Biol. 2007 179: 1219-1230
17725983 De Vos KJ et al.: Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content Hum. Mol. Genet. 2007 16: 2720-2728
12390515 Jung C et al.: Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis J. Neurochem. 2002 83: 535-545
15634778 Kirkinezos IG et al.: Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice J. Neurosci. 2005 25: 164-172
19240958 Lin J et al.: Specific electron transport chain abnormalities in amyotrophic lateral sclerosis J. Neurol. 2009 256: 774-782
12050154 Mattiazzi M et al.: Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice J. Biol. Chem. 2002 277
16903849 Raimondi A et al.: Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1 Eur. J. Neurosci. 2006 24: 387-399
15758154 Vijayvergiya C et al.: Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice J. Neurosci. 2005 25: 2463-2470
18703498 Kawamata H et al.: Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria Hum. Mol. Genet. 2008 17: 3303-3317
19320055 Son M et al.: Redox susceptibility of SOD1 mutants is associated with the differential response to CCS over-expression in vivo Neurobiol. Dis. 2009 34: 155-162
17620987 Jiang YM et al.: Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis J. Neuropathol. Exp. Neurol. 2007 66: 617-627
21078990 Li Q et al.: ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import Proc. Natl. Acad. Sci. U.S.A. 2010 107
21078990 Li Q et al.: ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import Proc. Natl. Acad. Sci. U.S.A. 2010 107
20797535 Israelson A et al.: Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS Neuron 2010 67: 575-587
20797535 Israelson A et al.: Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS Neuron 2010 67: 575-587
18296640 Vande Velde C et al.: Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria Proc. Natl. Acad. Sci. U.S.A. 2008 105: 4022-4027
19779023 Magrane J et al.: Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities Hum. Mol. Genet. 2009 18: 4552-4564
19272377 Martin LJ et al.: The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice Exp. Neurol. 2009 218: 333-346
19174508 Nguyen KT et al.: The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals Proc. Natl. Acad. Sci. U.S.A. 2009 106: 2007-2011
19404401 Dupuis L et al.: Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons PLoS ONE 2009 4: E5390
19158288 Jeong SY et al.: Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis J. Neurosci. 2009 29: 610-619
17394531 Zimmerman MC et al.: Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels J. Neurochem. 2007 102: 609-618
16702190 Wood-Allum CA et al.: Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen Brain 2006 129: 1693-1709
20127819 Morimoto N et al.: Induction of parkinsonism-related proteins in the spinal motor neurons of transgenic mouse carrying a mutant SOD1 gene J. Neurosci. Res. 2010 88: 1804-1811
18712292 Lev N et al.: DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. J. Mol. Neurosci. 2009 38: 94-102
17434459 Eve DJ et al.: Transcription factor p53 in degenerating spinal cords. Brain Res. 2007 1150: 174-181
17099894 Martin LJ et al.: Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J. Comp. Neurol. 2007 500: 20-46
19805546 Lu L et al.: Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor. J. Biol. Chem. 2009 284
17434152 Murakami T et al.: Early decrease of mitochondrial DNA repair enzymes in spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 gene. Brain Res. 2007 1150: 182-189
19900586 Loizzo S et al.: Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model. Mitochondrion 2010 10: 108-114
19379740 Bradley LJ et al.: Increased sensitivity of myoblasts to oxidative stress in amyotrophic lateral sclerosis peripheral tissues. Exp. Neurol. 2009 218: 92-97
18417691 Cassina P et al.: Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J. Neurosci. 2008 28: 4115-4122
21059924 Bilsland LG et al.: Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. U.S.A. 2010 107
20606625 Dormann D et al.: ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010 29: 2841-2857
25374358 Smith BN et al.: Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS Neuron 2014 84: 324-331
11803234 Croonenberghs J et al.: Activation of the inflammatory response system in autism. Neuropsychobiology 2002 45: 1-6
19157572 Li X et al.: Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009 207: 111-116
10693155 Croonenberghs J et al.: Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder Neuropsychopharmacology 2000 22: 275-283
10693155 Croonenberghs J et al.: Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology 2000 22: 275-283
21573053 Naik US et al.: A study of nuclear transcription factor-kappa B in childhood autism. PLoS ONE 2011 6
21521652 Al-ayadhi LY et al.: Increased serum osteopontin levels in autistic children: relation to the disease severity Brain Behav. Immun. 2011 25: 1393-1398
20705131 Ashwood P et al.: Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome Brain Behav. Immun. 2011 25: 40-45
12039413 Torres AR et al.: The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder Hum. Immunol. 2002 63: 311-316
21346746 Penzes P et al.: Dendritic spine pathology in neuropsychiatric disorders Nat. Neurosci. 2011 14: 285-293
23596459 Gilling M et al.: Dysfunction of the Heteromeric KV7.3/KV7.5 Potassium Channel is Associated with Autism Spectrum Disorders Front Genet 2013 4: 54
19289393 Ben-Shachar S et al.: Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders J. Med. Genet. 2009 46: 382-388
24776741 McCarthy SE et al.: De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability
24752249 Breitenkamp AF et al.: Rare mutations of CACNB2 found in autism spectrum disease-affected families alter calcium channel function PLoS ONE 2014 9
25707359 Chen N et al.: Interaction proteomics of canonical Caspr2 (CNTNAP2) reveals the presence of two Caspr2 isoforms with overlapping interactomes Biochim. Biophys. Acta 2015 7: 827-833
11074872 Guidotti A et al.: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study Arch. Gen. Psychiatry 2000 57: 1061-1069
17270400 Veldic M et al.: Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder Schizophr. Res. 2007 91: 51-61
19059449 Torres KC et al.: The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009 33: 214-219
20368704 Williams HJ et al.: Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder Mol. Psychiatry 2011 16: 429-441
16924267 Severinsen JE et al.: Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. Mol. Psychiatry 2006 11: 1126-1138
16484223 Assmann EM et al.: FEZ1 dimerization and interaction with transcription regulatory proteins involves its coiled-coil region J. Biol. Chem. 2006 281: 9869-9881
20569643 Hope S et al.: Osteoprotegerin levels in patients with severe mental disorders J Psychiatry Neurosci 2010 35: 304-310
19754466 OBrien WT et al.: Validating GSK3 as an in vivo target of lithium action. Biochem. Soc. Trans. 2009 37: 1133-1138
21176028 Beech RD et al.: Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord 2010 12: 813-824
20566748 Cataldo AM et al.: Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am. J. Pathol. 2010 177: 575-585
17485607 Naydenov AV et al.: Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch. Gen. Psychiatry 2007 64: 555-564
20368511 Andreazza AC et al.: Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 2010 67: 360-368
1728159 Dubovsky SL et al.: Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry 1992 149: 118-120
15737668 Munakata K et al.: Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 2005 57: 525-532
14993118 Konradi C et al.: Molecular evidence for mitochondrial dysfunction in bipolar disorder Arch. Gen. Psychiatry 2004 61: 300-308
16696827 MacDonald ML et al.: Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 2006 8: 255-264
18191109 Shao L et al.: Shared gene expression alterations in schizophrenia and bipolar disorder Biol. Psychiatry 2008 64: 89-97
19350560 Kahler AK et al.: Association study of PDE4B gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010 153B: 86-96
22428012 Li J et al.: Lithium impacts on the amplitude and period of the molecular circadian clockwork PLoS ONE 2012 7
22384149 McCarthy MJ et al.: A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response PLoS ONE 2012 7
11723175 Bezchlibnyk YB et al.: Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex J. Neurochem. 2001 79: 826-834
23231880 Manu P et al.: Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone Schizophr. Res. 2013 143: 358-362
20591414 Mukherjee S et al.: Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior Biol. Psychiatry 2010 68: 503-511
17259569 Varma MK et al.: Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature J Intensive Care Med 2007 22: 52-55
11673795 Kirov G et al.: Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder Mol. Psychiatry 2001 6: 671-677
21961650 Squassina A et al.: Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder Pharmacogenomics 2011 12: 1559-1569
20679588 Erk S et al.: Brain function in carriers of a genome-wide supported bipolar disorder variant Arch. Gen. Psychiatry 2010 67: 803-811
22831755 Meier S et al.: Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder Int. J. Neuropsychopharmacol. 2013 16: 549-556
21927946 Yamada K et al.: Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population Hum. Genet. 2012 131: 443-451
22017219 Backlund L et al.: Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder Bipolar Disord 2011 13: 500-508
21738484 Smith EN et al.: Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes PLoS Genet. 2011 7
23437964 Gonzalez S et al.: Suggestive evidence for association between L-type voltage-gated calcium channel (CACNA1C) gene haplotypes and bipolar disorder in Latinos: a family-based association study Bipolar Disord 2013 15: 206-214
24114586 Weston-Green K et al.: Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor CNS Drugs 2013 27: 1069-1080
22472876 Ripke S et al.: A mega-analysis of genome-wide association studies for major depressive disorder Mol. Psychiatry 2013 18: 497-511
24461634 Finseth PI et al.: Association analysis between suicidal behaviour and candidate genes of bipolar disorder and schizophrenia J Affect Disord 2014 163: 110-114
23974872 Ripke S et al.: Genome-wide association analysis identifies 13 new risk loci for schizophrenia Nat. Genet. 2013 45: 1150-1159
23880959 Wolf C et al.: CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia Eur Arch Psychiatry Clin Neurosci 2014 264: 93-102
15563509 Iwamoto K et al.: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis Hum. Mol. Genet. 2005 14: 241-253
23070075 Green EK et al.: Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample Mol. Psychiatry 2013 18: 1302-1307
17486107 Baum AE et al.: A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder Mol. Psychiatry 2008 13: 197-207
15722956 Pickard BS et al.: Candidate psychiatric illness genes identified in patients with pericentric inversions of chromosome 18 Psychiatr. Genet. 2005 15: 37-44
16733521 Borsotto M et al.: PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder Pharmacogenomics J. 2007 7: 123-132
18357389 Lee SJ et al.: Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways Oncol. Rep. 2008 19: 1007-1013
21601006 Yoganathan TN et al.: Integrin-linked kinase (ILK): a hot therapeutic target Biochem. Pharmacol. 2000 60: 1115-1119
23866964 Dong LH et al.: Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma J Hematol Oncol 2013 6: 53
20028864 Brown KA et al.: Obesity and breast cancer: progress to understanding the relationship Cancer Res. 2010 70: 4-7
19509226 Brown KA et al.: Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women Cancer Res. 2009 69: 5392-5399
15766664 Kim RH et al.: DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005 7: 263-273
11705844 Le Naour F et al.: Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 2001 7: 3328-3335
20971498 Berthier A et al.: PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells Hum. Pathol. 2011 42: 75-87
16850246 Greenlee H et al.: Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer Breast Cancer Res. Treat. 2007 102: 111-117
1935184 Lessner MW et al.: A student nurses experience in an ICU. Crit Care Nurse 1991 11: 12
16361546 Cobleigh MA et al.: Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes Clin. Cancer Res. 2005 11: 8623-8631
11410592 Castro-Rivera E et al.: Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem. 2001 276
15870704 Lewandowski SA et al.: Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity. Oncogene 2005 24: 4789-4798
16328059 Li SY et al.: Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer. Oncol. Rep. 2006 15: 221-225
17519015 De Luca A et al.: Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter. BMC Mol. Biol. 2007 8: 39
17510434 Lin Z et al.: Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res. 2007 67: 5017-5024
8195246 Krishnan V et al.: Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J. Biol. Chem. 1994 269
9626663 Sun G et al.: Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex. Mol. Endocrinol. 1998 12: 882-890
12432273 Weinstein-Oppenheimer CR et al.: The effects of beta-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line. Cancer Biol. Ther. 2002 1: 256-262
10733592 Perillo B et al.: 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol. 2000 20: 2890-2901
24495551 Mehta D et al.: Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling
21655990 Hadad S et al.: Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res. Treat. 2011 128: 783-794
18714348 Martin KJ et al.: Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE 2008 3: E2994
21120602 Paruthiyil S et al.: Estrogen receptor beta causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2 Breast Cancer Res. Treat. 2011 129: 777-784
17268063 Iso T et al.: Modulation of the expression of bloom helicase by estrogenic agents. Biol. Pharm. Bull. 2007 30: 266-271
19477925 Pedram A et al.: Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol. Biol. Cell 2009 20: 3374-3389
17942748 Boverhof DR et al.: Inhibition of estrogen-mediated uterine gene expression responses by dioxin Mol. Pharmacol. 2008 73: 82-93
18949048 Wang C et al.: Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells. PLoS ONE 2008 3: E3523
16010982 Vani G et al.: Effect of histone H1 on estrogen receptor status of human breast cancer MCF 7 cells. Mol. Cell. Biochem. 2005 272: 151-155
19221498 Alimova IN et al.: Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 2009 8: 909-915
14506733 Kawai H et al.: Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int. J. Cancer 2003 107: 353-358
17062558 Zakikhani M et al.: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006 66
21185374 Englert NA et al.: Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 2011 123: 140-150
12612058 Hodges LC et al.: Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. Mol. Cancer Res. 2003 1: 300-311
14605097 Wang DY et al.: Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol. Endocrinol. 2004 18: 402-411
16962797 Lee SU et al.: Protein profiling and transcript expression levels of heat shock proteins in 17beta-estradiol-treated human MCF-7 breast cancer cells. Cell Biol. Int. 2006 30: 983-991
17392432 Eakin CM et al.: Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 2007 104: 5794-5799
19887602 Ueki T et al.: Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 2009 69: 8752-8760
20501845 Zhao C et al.: Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res. 2010 70: 5174-5183
19434490 Treeck O et al.: Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. Breast Cancer Res. Treat. 2010 120: 557-565
17428314 Lin CY et al.: Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer Breast Cancer Res. 2007 9: R25
10766163 Liu G et al.: Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res. 2000 60: 1810-1814
15328371 Wang W et al.: TAFII70 isoform-specific growth suppression correlates with its ability to complex with the GADD45a protein Mol. Cancer Res. 2004 2: 442-452
17407970 Su T et al.: Dip1 inhibits growth and gene transcription in MCF-7 breast cancer cells J. Exp. Ther. Oncol. 2007 6: 117-127
10220405 Yarden RI et al.: BRCA1 interacts with components of the histone deacetylase complex Proc. Natl. Acad. Sci. U.S.A. 1999 96: 4983-4988
23288347 Yamada A et al.: High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival Breast Cancer Res. Treat. 2013 137: 773-782
12878187 Gauthier ML et al.: Protein kinase Calpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor Biochem. Biophys. Res. Commun. 2003 307: 839-846
22279420 Mohibi S et al.: Mouse models of estrogen receptor-positive breast cancer J Carcinog 2011 10: 35
19754359 van der Veeken J et al.: Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy Curr Cancer Drug Targets 2009 9: 748-760
18996184 Gaikwad NW et al.: Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones Free Radic. Biol. Med. 2009 46: 253-262
22386952 Pruthi S et al.: Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk J. Steroid Biochem. Mol. Biol. 2012 132: 73-79
16675129 Cavalieri E et al.: Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention Biochim. Biophys. Acta 2006 1766: 63-78
25110054 Do MT et al.: Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression Toxicol. Appl. Pharmacol. 2014 280: 138-148
19995559 Vinothini G et al.: Correlation of xenobiotic-metabolizing enzymes, oxidative stress and NFkappaB signaling with histological grade and menopausal status in patients with adenocarcinoma of the breast Clin. Chim. Acta 2010 411: 368-374
23576571 Rodriguez M et al.: CYP1A1 regulates breast cancer proliferation and survival Mol. Cancer Res. 2013 11: 780-792
23733406 Goode GD et al.: Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line Int. J. Cancer 2013 133: 2769-2780
14647449 Stoner M et al.: Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins Oncogene 2004 5: 1052-1063
23172368 Sotgia F et al.: Mitochondria fuel breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells Cell Cycle 2012 11: 4390-4401
24212942 Gupta N et al.: beta-Catenin Is a Positive Regulator of Estrogen Receptor-alpha Function in Breast Cancer Cells Cancers (Basel) 2011 3: 2990-3001
20838384 Kalra J et al.: Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1 Oncogene 2010 29: 6343-6356
16785428 Bose R et al.: Phosphoproteomic analysis of Her2/neu signaling and inhibition Proc. Natl. Acad. Sci. U.S.A. 2006 103: 9773-9778
21402692 Mitra R et al.: CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (+/-)-14,15-epoxyeicosatrienoic acid (EET) J. Biol. Chem. 2011 286
21054339 Kim HG et al.: Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation Br. J. Pharmacol. 2011 162: 1096-1108
21925487 Rudd LP et al.: Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1) Chem. Biol. Interact. 2011 194: 113-119
24667650 Sengupta D et al.: ERRbeta signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells Br. J. Cancer 2014 110: 2144-2158
10608854 Li Z et al.: IQGAP1 and calmodulin modulate E-cadherin function J. Biol. Chem. 1999 274
25801958 Citro S et al.: PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression J Mol Cell Biol 2015 7: 132-142
21737670 Nakagawa M et al.: Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer Anticancer Res. 2011 31: 2389-2393
17875716 Miao ZH et al.: Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses Cancer Res. 2007 67: 8752-8761
20615467 Maeda T et al.: Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer J. Steroid Biochem. Mol. Biol. 2010 122: 180-185
24754247 Gozalpour E et al.: Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3 Mol. Pharm. 2014 11: 1844-1855
19682730 Gupta PB et al.: Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 2009 138: 645-659
23730416 Hayman TJ et al.: Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity Transl Oncol 2013 3: 355-362
24831777 Banerjee N et al.: Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues Breast Cancer Res. Treat. 2014 145: 647-661
26378621 Zhang W et al.: Tris(2-chloroethyl)phosphate-induced cell growth arrest via attenuation of SIRT1-independent PI3K/Akt/mTOR pathway J Appl Toxicol 2016 36: 914-924
21339306 Tiraby C et al.: Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth Cancer Res. 2011 71: 2518-2528
21566910 Vandewalle B et al.: Effect of calcium on e-cadherin expression in breast-tumor cells Int. J. Oncol. 1994 4: 181-185
18521741 Lanzino M et al.: Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells Breast Cancer Res. Treat. 2009 115: 297-306
22025613 Dong C et al.: Regulation of alpha(2B)-adrenergic receptor-mediated extracellular signal-regulated kinase 1/2 (ERK1/2) activation by ADP-ribosylation factor 1 J. Biol. Chem. 2011 286
11072781 Jeng MH et al.: Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells Breast Cancer Res. Treat. 2000 62: 167-175
20353938 Ingermann AR et al.: Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer J. Biol. Chem. 2010 285
24304688 McGuirk S et al.: PGC-1alpha supports glutamine metabolism in breast cancer Cancer Metab 2013 1: 22
14500345 Oesterreich S et al.: Estrogen-mediated down-regulation of E-cadherin in breast cancer cells Cancer Res. 2003 63: 5203-5208
19943104 Jin W et al.: UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer Breast Cancer Res. Treat. 2010 123: 359-373
26621032 Holt SH et al.: Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells J. Cell. Sci. 2016 129: 155-165
23959881 Sohn YS et al.: NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth Proc. Natl. Acad. Sci. U.S.A. 2013 110
19946270 Veeriah S et al.: Somatic mutations of the Parkinsons disease-associated gene PARK2 in glioblastoma and other human malignancies Nat. Genet. 2010 42: 77-82
9842892 Piguet PF et al.: TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53 Eur. J. Immunol. 1998 28: 3499-3505
21602532 Cheng I et al.: Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies. Gut 2011 60: 1703-1711
18172327 Gunter MJ et al.: Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 2008 68: 329-337
21674030 Okyar A et al.: Strain- and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileum PLoS ONE 2011 6
21931543 Ballesta A et al.: A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery PLoS Comput. Biol. 2011 7
17591803 Koda M et al.: Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer Ann. Oncol. 2007 18: VI116-VI119
26124005 Wang Z et al.: Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-kappaB signaling and suppressing cAMP-responsive element transcriptional activity
25165391 Zhu X et al.: Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study J. Nutr. 2014 144: 1734-1741
11470825 Palmer HG et al.: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling J. Cell Biol. 2001 154: 369-387
21514270 Kouchi Z et al.: Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells Biochem. Biophys. Res. Commun. 2011 408: 523-529
25559195 Takeda H et al.: Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression Nat. Genet. 2015 47: 142-150
25427913 Singh S et al.: Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers Adv. Exp. Med. Biol. 2015 815: 281-294
26579434 Ridlon JM et al.: The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics Acta Pharm Sin B 2015 5: 99-105
19051325 Shaffer JM et al.: Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer Genes Chromosomes Cancer 2009 48: 272-284
18216263 Wunderlich FT et al.: Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis Proc. Natl. Acad. Sci. U.S.A. 2008 105: 1297-1302
18932288 Lee CF et al.: Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma World J. Gastroenterol. 2008 14: 6072-6077
12764143 Mottet D et al.: Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells J. Biol. Chem. 2003 278
9442036 Cha HH et al.: Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells J. Biol. Chem. 1998 273: 1998-2007
11741912 Adilakshmi T et al.: Ribosomal protein S25 mRNA partners with MTF-1 and La to provide a p53-mediated mechanism for survival or death J. Biol. Chem. 2002 277: 4147-4151
15611046 McMahon S et al.: Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins J. Biol. Chem. 2005 280: 6561-6569
25796501 Wang W et al.: Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma Med. Oncol. 2015 32: 131
24448241 Noh JH et al.: HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT Cancer Res. 2014 74: 1728-1738
20099302 Soll C et al.: Serotonin promotes tumor growth in human hepatocellular cancer Hepatology 2010 51: 1244-1254
26052399 Ampuero J et al.: Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin World J Hepatol 2015 7: 1105-1111
20351271 Suzuki S et al.: Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species Proc. Natl. Acad. Sci. U.S.A. 2010 107: 7461-7466
24797434 Liu J et al.: Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma Oncotarget 2014 5: 2635-2647
25915584 author information missing Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis J. Clin. Invest. 2015 125: 2293-2306
25844758 author information missing article information missing
20176206 Mauchley D et al.: Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A(2) J. Thorac. Cardiovasc. Surg. 2010 139: 591-599
19946270 Veeriah S et al.: Somatic mutations of the Parkinsons disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 2010 42: 77-82
23408368 Fan S et al.: Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma Med. Oncol. 2013 30: 384
12584187 Berdiev BK et al.: Acid-sensing ion channels in malignant gliomas J. Biol. Chem. 2003 278
20368557 Liu Y et al.: Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival J. Clin. Oncol. 2010 28: 2467-2474
24582898 Li W et al.: MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression Neurosci. Lett. 2014 566: 82-87
25898313 Daniele S et al.: Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells Sci Rep 2015 5: 9956
25867026 Sesen J et al.: Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response PLoS ONE 2015 10
25222834 Cuperlovic-Culf M et al.: Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide Metabolites 2014 4: 807-830
23625692 Sami A et al.: Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding Tumour Biol. 2013 34: 1991-2002
15578701 Camphausen K et al.: Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid Int. J. Cancer 2005 114: 380-386
21362133 Shabason JE et al.: Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic J. Cell. Mol. Med. 2011 15: 2735-2744
24418474 Choi EJ et al.: Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases BMC Cancer 2014 14: 17
20372862 Zhao N et al.: Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation Oncol. Rep. 2010 23: 1443-1447
19827268 Jiang H et al.: Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells J. Exp. Ther. Oncol. 2009 8: 25-33
18772890 author information missing Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 2008 455: 1061-1068
15143086 Chakravarti A et al.: The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas J. Clin. Oncol. 2004 22: 1926-1933
24096582 Szeliga M et al.: Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells Tumour Biol. 2014 35: 1855-1862
24276018 Martin-Rufian M et al.: Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells J. Mol. Med. 2014 92: 277-290
26119730 LaGory EL et al.: Suppression of PGC-1alpha Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma Cell Rep 2015 12: 116-127
25344677 Guo Z et al.: KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma Tumour Biol. 2015 36: 1251-1259
25473003 Shou Y et al.: A Five-Gene Hedgehog Signature Developed as a Patient Preselection Tool for Hedgehog Inhibitor Therapy in Medulloblastoma
22525724 Li W et al.: SBF-1, a synthetic steroidal glycoside, inhibits melanoma growth and metastasis through blocking interaction between PDK1 and AKT3 Biochem. Pharmacol. 2012 84: 172-181
16778180 Furuta J et al.: Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas Cancer Res. 2006 66: 6080-6086
21537389 author information missing A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study) Int J Mol Epidemiol Genet 2010 1: 175-183
17603485 Gudmundsson J et al.: Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Nat. Genet. 2007 39: 977-983
20203524 Pierce BL et al.: Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. Hum. Hered. 2010 69: 193-201
18835745 Ma J et al.: Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008 9: 1039-1047
15059908 Chesire DR et al.: Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells Cancer Res. 2004 64: 2523-2533
20807808 Zhu ML et al.: Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer Cancer Res. 2010 70: 7992-8002
15598662 Hodgson MC et al.: The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists J. Biol. Chem. 2005 280: 6511-6519
19021144 Mamaeva OA et al.: Calcium/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells J. Cell. Biochem. 2009 106: 25-32
18519708 Montgomery RB et al.: Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth Cancer Res. 2008 68: 4447-4454
18384941 Ummanni R et al.: Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer Cancer Lett. 2008 266: 171-185
18519708 Montgomery RB et al.: Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth Cancer Res. 2008 11: 4447-4454
24717169 Carter RC et al.: Effects of prenatal alcohol exposure on testosterone and pubertal development Alcohol. Clin. Exp. Res. 2014 38: 1671-1679
24779401 Makarevic J et al.: Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells J. Cell. Mol. Med. 2014 18: 1460-1466
23687346 Fendt SM et al.: Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism Cancer Res. 2013 73: 4429-4438
26002551 Loubiere C et al.: Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells Oncotarget 2015 6
14583493 MacKeigan JP et al.: Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res. 2003 63: 6928-6934
15976810 Shinbo Y et al.: Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ. 2006 13: 96-108
17237272 Oguri T et al.: MRP8/ABCC11 directly confers resistance to 5-fluorouracil Mol. Cancer Ther. 2007 6: 122-127
22544838 Ware JJ et al.: From men to mice: CHRNA5/CHRNA3, smoking behavior and disease Nicotine Tob. Res. 2012 14: 1291-1299
18978787 Wang Y et al.: Common 5p15.33 and 6p21.33 variants influence lung cancer risk Nat. Genet. 2008 40: 1407-1409
21559498 Wang Y et al.: Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk PLoS ONE 2011 6
19654303 Broderick P et al.: Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study Cancer Res. 2009 69: 6633-6641
23872218 Flora AV et al.: Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors Brain Res. 2013 1529: 1-15
25884493 Etokebe GE et al.: Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations PLoS ONE 2015 10
20081861 Houghton AM et al.: Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth Nat. Med. 2010 16: 219-223
23420440 Chou CH et al.: SCUBE3 regulation of early lung cancer angiogenesis and metastatic progression Clin. Exp. Metastasis 2013 30: 741-752
21441952 Wu YY et al.: SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer Oncogene 2011 30: 3682-3693
20473924 Schulte JH et al.: Accurate prediction of neuroblastoma outcome based on miRNA expression profiles Int. J. Cancer 2010 127: 2374-2385
10803465 Eggert A et al.: Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells Oncogene 2000 19: 2043-2051
15322108 Bryan B et al.: GEFT, a Rho family guanine nucleotide exchange factor, regulates neurite outgrowth and dendritic spine formation J. Biol. Chem. 2004 279
18413728 Molenaar JJ et al.: Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma Cancer Res. 2008 68: 2599-2609
24912852 De Antonellis P et al.: Early targets of miR-34a in neuroblastoma Mol. Cell Proteomics 2014 13: 2114-2131
19651775 Mascarenhas JB et al.: PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene J. Biol. Chem. 2009 284
19375425 Li D et al.: Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 2009 137: 482-488
22590527 Hou J et al.: FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer PLoS ONE 2012 7
23803693 Nair V et al.: Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors Carcinogenesis 2013 12: 2870-2879
26164081 Cohen R et al.: Targeting cancer cell metabolism in pancreatic adenocarcinoma Oncotarget 2015 19
18784743 Nishioka C et al.: Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells Leukemia 2008 22: 2159-2168
22932805 Khandanpour C et al.: The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice Blood 2012 120: 4006-4017
19996286 Lin LF et al.: ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer. Cancer Res. 2010 70: 192-201
14985505 Shaw RJ et al.: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 2004 101: 3329-3335
12771025 Li J et al.: AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression Carcinogenesis 2003 24: 827-834
19885556 Kim YC et al.: Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. Int. J. Oncol. 2009 35: 1331-1341
20510502 Ren H et al.: DJ-1, a cancer and Parkinsons disease associated protein, regulates autophagy through JNK pathway in cancer cells Cancer Lett. 2010 297: 101-108
21912508 Braun S et al.: The link between the metabolic syndrome and cancer Int. J. Biol. Sci. 2011 7: 1003-1015
19564453 Libby G et al.: New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009 32: 1620-1625
20947488 Decensi A et al.: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2010 3: 1451-1461
19918015 Landman GW et al.: Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 2010 33: 322-326
19082520 Monami M et al.: Sulphonylureas and cancer: a case-control study. Acta Diabetol 2009 46: 279-284
16443869 Bowker SL et al.: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006 29: 254-258
18006825 Dowling RJ et al.: Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 2007 67
22132214 Jung JW et al.: Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression. PLoS ONE 2011 6
18212742 Ben Sahra I et al.: The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 2008 27: 3576-3586
19822355 Cantrell LA et al.: Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. Gynecol. Oncol. 2010 116: 92-98
17447005 Isakovic A et al.: Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell. Mol. Life Sci. 2007 64: 1290-1302
19440038 Liu B et al.: Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 2009 8: 2031-2040
19491931 Chen W et al.: Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. Eur. J. Hum. Genet. 2009 17: 1668-1675
18497064 Hontz AE et al.: Expression of selected Aurora A kinase substrates in solely estrogen-induced ectopic uterine stem cell tumors in the Syrian hamster kidney. Adv. Exp. Med. Biol. 2008 617: 411-418
22266860 Chuang JY et al.: Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells Oncogene 2012 31: 4946-4959
20679220 Ueda T et al.: Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development Proc. Natl. Acad. Sci. U.S.A. 2010 107
11463832 Knauf U et al.: Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2 Mol. Cell. Biol. 2001 21: 5500-5511
22392765 Hou J et al.: Targeting Mnks for cancer therapy Oncotarget 2012 3: 118-131
15345718 Legembre P et al.: Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness J. Biol. Chem. 2004 279
20458141 van de Sluis B et al.: COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion J. Clin. Invest. 2010 120: 2119-2130
20482850 Wu G et al.: A human functional protein interaction network and its application to cancer data analysis Genome Biol. 2010 11: R53
22259062 Peverelli E et al.: Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs J. Clin. Endocrinol. Metab. 2012 97: 967-977
12469206 Katoh M et al.: Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by beta-estradiol in MCF-7 cells Int. J. Oncol. 2003 22: 209-212
10572067 Fernandes AM et al.: Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity Am. J. Respir. Cell Mol. Biol. 1999 21: 701-709
10862525 Li DN et al.: Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol Pharmacogenetics 2000 10: 343-353
15304487 Kouzmenko AP et al.: Wnt/beta-catenin and estrogen signaling converge in vivo J. Biol. Chem. 2004 279
21388974 author information missing article information missing
17138652 Lehnes K et al.: The effect of estradiol on in vivo tumorigenesis is modulated by the human epidermal growth factor receptor 2/phosphatidylinositol 3-kinase/Akt1 pathway Endocrinology 2007 148: 1171-1180
17410209 Li J et al.: CBP/p300 are bimodal regulators of Wnt signaling EMBO J. 2007 26: 2284-2294
14749120 Clevers H et al.: Wnt breakers in colon cancer Cancer Cell 2004 5: 5-6
18172554 Zudaire E et al.: The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers J. Clin. Invest. 2008 118: 640-650
21976023 Opitz CA et al.: An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 2011 478: 197-203
10329476 Kolla V et al.: Upregulation of mineralocorticoid- and glucocorticoid-receptor gene expression by Sp-I Mol. Cell Biol. Res. Commun. 1999 1: 44-47
19376845 Beedanagari SR et al.: Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes Toxicol. Sci. 2009 110: 61-67
19018768 Choi H et al.: Curcumin attenuates cytochrome P450 induction in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently degrading AhR and ARNT Cancer Sci. 2008 99: 2518-2524
21878739 Terashima J et al.: Induction of CYP1 family members under low-glucose conditions requires AhR expression and occurs through the nuclear translocation of AhR Drug Metab. Pharmacokinet. 2011 26: 577-583
11279538 Lee YS et al.: Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells Cell Death Differ. 2000 7: 925-932
24049067 Garcia-Jimenez C et al.: A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose J. Mol. Endocrinol. 2013 52: R51-R66
23500545 de Weille J et al.: Oxysterols in cancer cell proliferation and death Biochem. Pharmacol. 2013 86: 154-160
21239045 Feng Z et al.: Mammalian target of rapamycin regulates expression of beta-catenin in hepatocellular carcinoma Hum. Pathol. 2011 42: 659-668
23657817 Boscher C et al.: Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells Mol. Biol. Cell 2013 24: 2134-2145
21719054 Taylor CJ et al.: Integrin-linked kinase regulates phosphatase and tensin homologue activity to promote tumorigenesis in neuroblastoma cells Surgery 2011 150: 162-168
23796563 Antico Arciuch VG et al.: Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells Cancer Res. 2013 73: 5459-5472
18339839 McDonald PC et al.: Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival Cancer Res. 2008 68: 1618-1624
24072782 Lamming DW et al.: Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2) FASEB J. 2014 28: 300-315
11719506 Yoon JW et al.: Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation J. Biol. Chem. 2002 277: 5548-5555
19706761 Lo HW et al.: A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion Cancer Res. 2009 69: 6790-6798
15737636 Hu H et al.: Alpha-actinin-2, a cytoskeletal protein, binds to angiogenin Biochem. Biophys. Res. Commun. 2005 329: 661-667
24947164 Bavarva JH et al.: Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes Oncotarget 2014 5: 4788-4798
25281745 Cole SP et al.: Multidrug resistance protein 1 (MRP1, ABCC1), a multitasking ATP-binding cassette (ABC) transporter J. Biol. Chem. 2014 289
26180030 Ho CH et al.: Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
24345474 author information missing Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas Genome Biol. 2013 14: R137
25367630 Kiehl S et al.: ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth Sci Rep 2014 4: 6899
23147569 Kurundkar D et al.: Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model Toxicol. Appl. Pharmacol. 2013 266: 233-244
25060902 Kowshik J et al.: Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model Anticancer Agents Med Chem 2014 14: 1249-1260
23965899 Dai W et al.: Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer Clin. Cancer Res. 2013 19: 5788-5797
14578676 Kraus LA et al.: The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation Invest New Drugs 2003 21: 259-268
23608536 Aschauer L et al.: Delineation of the key aspects in the regulation of epithelial monolayer formation Mol. Cell. Biol. 2013 33: 2535-2550
25945730 Mariani A et al.: Differential Targeting of Human Topoisomerase II Isoforms with Small Molecules J. Med. Chem. 2015 58: 4851-4856
24186357 de Souza WF et al.: Ouabain-induced alterations of the apical junctional complex involve alpha1 and beta1 Na,K-ATPase downregulation and ERK1/2 activation independent of caveolae in colorectal cancer cells J. Membr. Biol. 2014 247: 23-33
20610891 Yamaguchi H et al.: Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1 Drug Metab. Pharmacokinet. 2010 25: 314-317
14993604 Mikkaichi T et al.: Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney Proc. Natl. Acad. Sci. U.S.A. 2004 101: 3569-3574
15050519 Geyer J et al.: Molecular cloning and functional characterization of the bovine (Bos taurus) organic anion transporting polypeptide Oatp1a2 (Slco1a2) Comp. Biochem. Physiol. B 2004 137: 317-329
12351693 Pizzagalli F et al.: Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter Mol. Endocrinol. 2002 16: 2283-2296
19775282 Tammam J et al.: Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia Br. J. Pharmacol. 2009 158: 1183-1195
20332460 Okuhashi Y et al.: Effects of gamma-secretase inhibitors on the growth of leukemia cells Anticancer Res. 2010 30: 495-498
15448035 Dutcher JP et al.: Mammalian target of rapamycin inhibition Clin. Cancer Res. 2004 10: 6382
21652061 Kiewisz J et al.: Gene expression of WNTs, beta-catenin and E-cadherin during the periimplantation period of pregnancy in pigs--involvement of steroid hormones Theriogenology 2011 76: 687-699
18000824 Peng D et al.: Alterations in Barretts-related adenocarcinomas: a proteomic approach Int. J. Cancer 2008 122: 1303-1310
24382387 author information missing New and emerging HDAC inhibitors for cancer treatment J. Clin. Invest. 2014 124: 30-39
25247487 Erdem M et al.: herg1b expression as a potential specific marker in pediatric acute myeloid leukemia patients with HERG 897K/K genotype Pediatr Hematol Oncol 2015 32: 182-192
25098424 Prada J et al.: Significant decreases of interleukin-1alpha gene expression after application of the serotonin receptor antagonist ondansetron are found to correlate with antiproliferative properties in the acute lymphoblastic leukemia cell line REH Leuk. Lymphoma 2015 56: 1157-1159
25674239 Quesada AE et al.: Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-kappaB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options Int J Clin Exp Pathol 2014 7: 8732-8739
12431979 Crociani O et al.: Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells J. Biol. Chem. 2003 278: 2947-2955
24570000 Tanaka T et al.: Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells J. Biol. Chem. 2014 289
9029730 Labrie F et al.: The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology Steroids 1997 62: 148-158
20435002 Juntti SA et al.: The androgen receptor governs the execution, but not programming, of male sexual and territorial behaviors Neuron 2010 66: 260-272
23591044 Chuffa LG et al.: Melatonin and ethanol intake exert opposite effects on circulating estradiol and progesterone and differentially regulate sex steroid receptors in the ovaries, oviducts, and uteri of adult rats Reprod. Toxicol. 2013 39: 40-49
22375794 Kirpich I et al.: Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3 Alcohol. Clin. Exp. Res. 2012 36: 1578-1586
7424707 et al.: Acetaldehyde directly inhibits the conversion of androstenedione to testosterone in the testes Adv. Exp. Med. Biol. 1980 132: 211-217
14534309 Ali MK et al.: Elevated intracellular calcium triggers recruitment of the receptor cross-talk accessory protein calcyon to the plasma membrane J. Biol. Chem. 2003 278
8631893 Edelman AM et al.: Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat brain. Purification, regulation by Ca(2+)-calmodulin, and partial amino acid sequence J. Biol. Chem. 1996 271
22212478 Anastasiou D et al.: Breathless cancer cells get fat on glutamine Cell Res. 2012 3: 443-446
21540236 Ben Sahra I et al.: Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1 Cancer Res. 2011 71: 4366-4372
11130979 Aledo JC et al.: Identification of two human glutaminase loci and tissue-specific expression of the two related genes Mamm. Genome 2000 11: 1107-1110
11015561 Elgadi KM et al.: Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing Physiol. Genomics 1999 1: 51-62
19428809 Szeliga M et al.: Glutamine in neoplastic cells: focus on the expression and roles of glutaminases Neurochem. Int. 2009 55: 71-75
22665485 Hyodo T et al.: Misshapen-like kinase 1 (MINK1) is a novel component of striatin-interacting phosphatase and kinase (STRIPAK) and is required for the completion of cytokinesis J. Biol. Chem. 2012 287
25250919 Wong M et al.: Silencing of STRN4 suppresses the malignant characteristics of cancer cells Cancer Sci. 2014 105: 1526-1532
15469942 Hu Y et al.: Identification and functional characterization of a novel human misshapen/Nck interacting kinase-related kinase, hMINK beta J. Biol. Chem. 2004 279
26240284 Li Y et al.: Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway Mol. Cell. Biol. 2015 35: 3547-3565
22117616 Viollet B et al.: Cellular and molecular mechanisms of metformin: an overview Clin. Sci. 2012 122: 253-270
20510874 Kitamoto S et al.: Promoter hypomethylation contributes to the expression of MUC3A in cancer cells Biochem. Biophys. Res. Commun. 2010 397: 333-339
17885581 Heimerl S et al.: Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells Melanoma Res. 2007 17: 265-273
14973057 Yasui K et al.: Alteration in copy numbers of genes as a mechanism for acquired drug resistance Cancer Res. 2004 64: 1403-1410
19460998 Vander Heiden MG et al.: Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 2009 5930: 1029-1033
25672512 Ngo DC et al.: Introduction to the molecular basis of cancer metabolism and the Warburg effect Mol. Biol. Rep. 2015 42: 819-823
23770033 Ishibashi Y et al.: New insights on glucosylated lipids: metabolism and functions Biochim. Biophys. Acta 2013 1831: 1475-1485
24482631 Cantoria MJ et al.: Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells Metabolomics 2014 10: 91-104
21496237 Alhosin M et al.: Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties J. Exp. Clin. Cancer Res. 2011 30: 41
21214517 Tien AL et al.: UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis Biochem. J. 2011 435: 175-185
22094461 Di Fulvio M et al.: Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action J. Biol. Chem. 2012 287: 393-407
12972546 Kogata N et al.: Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells Mol. Biol. Cell 2003 9: 3553-3564
21159660 Zhang S et al.: Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages Cancer Res. 2011 71: 1465-1473
11994747 Greer P et al.: Closing in on the biological functions of Fps/Fes and Fer Nat. Rev. Mol. Cell Biol. 2002 3: 278-289
23327920 Heideman MR et al.: Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function Blood 2013 121: 2038-2050
22286234 Hwang IY et al.: pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases Mol. Cells 2012 33: 195-201
27456357 Zhao Y et al.: Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma
26549013 Du WQ et al.: The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer Expert Opin. Ther. Targets 2016 20: 477-485
15280358 Zheng G et al.: ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation J. Biol. Chem. 2004 279
14993291 Frederick JP et al.: Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element Mol. Cell. Biol. 2004 24: 2546-2559
26927084 Mico V et al.: Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health Int J Mol Sci 2016 3: 299
10546001 Heaney AP et al.: Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat. Med. 1999 5: 1317-1321
19668232 Chan CB et al.: NGF inhibits human leukemia proliferation by downregulating cyclin A1 expression through promoting acinus/CtBP2 association Oncogene 2009 28: 3825-3836
10845904 Khanna-Gupta A et al.: Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation Blood 2000 95: 3734-3741
21263198 Lizcano F et al.: Thyroid hormone therapy modulates hypothalamo-pituitary-adrenal axis Endocr. J. 2011 58: 137-142
17875692 Pamidi A et al.: Functional interplay of p53 and Mus81 in DNA damage responses and cancer. Cancer Res. 2007 67: 8527-8535
21092550 Chen YH et al.: [Regulation of Bub1 mRNA expression in endometrial carcinoma Ishikawa cells by estrogen and paclitaxel]. Zhonghua Fu Chan Ke Za Zhi 2010 45: 686-690
18850582 Hrzenjak A et al.: SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway J. Pathol. 2008 216: 495-504
20442286 Aryee DN et al.: Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewings sarcoma cells in vitro Cancer Res. 2010 70: 4015-4023
21798848 Miller S et al.: Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma Neuro-oncology 2011 13: 866-879
16270043 Marasca R et al.: Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status Leukemia 2006 1: 103-114
17047052 Ng AP et al.: Cleavage of misfolded nuclear receptor corepressor confers resistance to unfolded protein response-induced apoptosis Cancer Res. 2006 66: 9903-9912
20331975 Shen R et al.: Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer Biochem. Biophys. Res. Commun. 2010 4: 1047-1052
25005785 Wang L et al.: LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of beta-catenin J. Cancer Res. Clin. Oncol. 2014 140: 1997-2008
24124332 Yim DH et al.: ITGA1 polymorphisms and haplotypes are associated with gastric cancer risk in a Korean population World J. Gastroenterol. 2013 35: 5870-5876
26060493 Park KK et al.: Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection Gastroenterol Res Pract 2015 2015
20062084 Mejias-Luque R et al.: Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors Oncogene 2010 29: 1753-1762
18519687 Ganesan K et al.: Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene Cancer Res. 2008 68: 4277-4286
17938585 Shao XD et al.: Expression and significance of HERG protein in gastric cancer Cancer Biol. Ther. 2008 7: 45-50
25756516 Subbannayya Y et al.: Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma Cancer Biol. Ther. 2015 16: 336-345
26565812 Wang L et al.: Overexpressed CISD2 has prognostic value in human gastric cancer and promotes gastric cancer cell proliferation and tumorigenesis via AKT signaling pathway Oncotarget 2016 7: 3791-3805
21480392 Goode EL et al.: Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk Mol. Carcinog. 2011 50: 397-402
26695144 Li N et al.: miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R Tumour Biol. 2016 37: 7767-7776
19641186 Gupta M et al.: Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2 Blood 2009 14: 2926-2935
25070836 Rahmani M et al.: PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo Clin. Cancer Res. 2014 20: 4849-4860
17588536 Sun GD et al.: The endoplasmic reticulum stress-inducible protein Niban regulates eIF2alpha and S6K1/4E-BP1 phosphorylation Biochem. Biophys. Res. Commun. 2007 360: 181-187
23143191 Clemen CS et al.: Desminopathies: pathology and mechanisms Acta Neuropathol. 2013 125: 47-75
11329061 Pashmforoush M et al.: Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy Nat. Med. 2001 7: 591-597
20373002 Ahmad S et al.: Decreased myocardial expression of dystrophin and titin mRNA and protein in dilated cardiomyopathy: possibly an adverse effect of TNF-alpha J. Clin. Immunol. 2010 30: 520-530
16951252 White DE et al.: Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure Genes Dev. 2006 20: 2355-2360
15541368 Minamisawa S et al.: Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies Biochem. Biophys. Res. Commun. 2004 325: 852-856
19652092 Liang X et al.: Targeted ablation of PINCH1 and PINCH2 from murine myocardium results in dilated cardiomyopathy and early postnatal lethality Circulation 2009 120: 568-576
22905185 Frock RL et al.: Cardiomyocyte-specific expression of lamin a improves cardiac function in Lmna-/- mice PLoS ONE 2012 7
25208486 Traister A et al.: Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function Nat Commun 2014 5: 4533
24315344 Peled Y et al.: Titin mutation in familial restrictive cardiomyopathy Int. J. Cardiol. 2014 171: 24-30
16376610 Arbustini E et al.: Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects Eur. J. Heart Fail. 2006 8: 477-483
26472190 Teo LY et al.: Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies
25813360 Zhang L et al.: Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy Arch. Biochem. Biophys. 2015 573: 69-76
26666891 Brodehl A et al.: Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy
26163040 Wu W et al.: Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing
25541130 Huby AC et al.: Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy J. Am. Coll. Cardiol. 2014 64: 2765-2776
23906401 Yang SW et al.: [Clinical characteristics and genetic analysis of three pediatric patients with idiopathic restrictive cardiomyopathy] Zhonghua Xin Xue Guan Bing Za Zhi 2013 41: 304-309
8631348 Freiburg A et al.: A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy Eur. J. Biochem. 1996 235: 317-323
19233194 Luckey SW et al.: The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy J. Mol. Cell. Cardiol. 2009 46: 739-747
24327207 Lee YK et al.: Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells Pflugers Arch. 2014 466: 1831-1844
24819921 Greeley NR et al.: Cross-sectional analysis of glucose metabolism in Friedreich ataxia J. Neurol. Sci. 2014 342: 29-35
16263703 Schulz TJ et al.: Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited J. Biol. Chem. 2006 281: 977-981
23280845 Cnop M et al.: Central role and mechanisms of beta-cell dysfunction and death in friedreich ataxia-associated diabetes Ann. Neurol. 2012 72: 971-982
11175786 Puccio H et al.: Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits Nat. Genet. 2001 27: 181-186
10899450 Vorgerd M et al.: Mitochondrial impairment of human muscle in Friedreich ataxia in vivo Neuromuscul. Disord. 2000 10: 430-435
19376812 Coppola G et al.: Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreichs ataxia Hum. Mol. Genet. 2009 18: 2452-2461
12925693 Ristow M et al.: Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass J. Clin. Invest. 2003 112: 527-534
11986241 Becker EM et al.: Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization Blood 2002 99: 3813-3822
23552101 Bayot A et al.: Cis-silencing of PIP5K1B evidenced in Friedreichs ataxia patient cells results in cytoskeleton anomalies Hum. Mol. Genet. 2013 22: 2894-2904
20975743 Chou JY et al.: Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy Nat Rev Endocrinol 2010 6: 676-688
25064003 Kuzaj P et al.: ABCC6- a new player in cellular cholesterol and lipoprotein metabolism? }, authors { names std { { name ml Kuzaj P }, { name ml Kuhn J }, { name ml Dabisch-Ruthe M }, { name ml Faust I }, { name ml Gotting C }, { name ml Knabbe C }, { name ml Hendig D, affil str Herz- und Diabeteszentrum NRW, Institut fur Laboratoriums- und Transfusionsmedizin, Universitatsklinik der Ruhr-Universitat Bochum, Georgstrasse 11, 32 545 Bad Oeynhausen, Germany. dhendig@hdz-nrw.de Lipids Health Dis 2014 13: 118
25265166 Kuzaj P et al.: Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls PLoS ONE 2014 9
23248644 Le Saux O et al.: The molecular and physiological roles of ABCC6: more than meets the eye Front Genet 2012 3: 289
16261549 Pasquali-Ronchetti I et al.: Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations J. Pathol. 2006 208: 54-61
22606356 Koch AJ et al.: Loss of emerin alters myogenic signaling and miRNA expression in mouse myogenic progenitors PLoS ONE 2012 7
21391237 Liang WC et al.: TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy Ann. Neurol. 2011 69: 1005-1013
15671068 Zhang Q et al.: Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle J. Cell. Sci. 2005 118: 673-687
11823453 Vatta M et al.: Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome Hum. Mol. Genet. 2002 11: 337-345
23414114 Risgaard B et al.: High prevalence of genetic variants previously associated with Brugada syndrome in new exome data Clin. Genet. 2013 84: 489-495
11238270 Ichida F et al.: Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome Circulation 2001 103: 1256-1263
20809236 Lardizabal JA et al.: The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus Curr Cardiol Rep 2010 12: 464-471
22155456 Schou J et al.: Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease Arterioscler. Thromb. Vasc. Biol. 2012 32: 506-515
24213632 Erdmann J et al.: Dysfunctional nitric oxide signalling increases risk of myocardial infarction Nature 2013 504: 432-436
16391217 Schulman SP et al.: L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial JAMA 2006 295: 58-64
19800018 Beigi F et al.: Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON Nitric Oxide 2009 21: 226-233
15166093 Zhou S et al.: Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs Circ. Res. 2004 95: 76-83
15601581 Dent MR et al.: Expression of phospholipase D isozymes in scar and viable tissue in congestive heart failure due to myocardial infarction J. Cell. Mol. Med. 2004 8: 526-536
24184252 Pfister O et al.: FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes J. Am. Coll. Cardiol. 2014 63: 1011-1019
24558405 Ghosh R et al.: Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxide PLoS ONE 2014 9
19726439 Jung C et al.: Arginase inhibition mediates cardioprotection during ischaemia-reperfusion Cardiovasc. Res. 2010 85: 147-154
22860052 Gonon AT et al.: Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production PLoS ONE 2012 7
24736300 Yoshino S et al.: Single nucleotide polymorphisms associated with abnormal coronary microvascular function Coron. Artery Dis. 2014 25: 281-289
26888119 Takeda N et al.: Circadian clock and the onset of cardiovascular events Hypertens. Res. 2016 39: 383-390
18316400 Bertolucci C et al.: Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillators Mol. Cell. Biol. 2008 9: 3070-3075
21317191 Takeda Y et al.: Retinoic acid-related orphan receptor gamma directly regulates neuronal PAS domain protein 2 transcription in vivo Nucleic Acids Res. 2011 11: 4769-4782
17627769 Parsons SA et al.: The Fps/Fes kinase regulates leucocyte recruitment and extravasation during inflammation Immunology 2007 4: 542-550
19943878 Kondkar AA et al.: VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA J. Thromb. Haemost. 2010 8: 369-378
26725916 Gao Y et al.: Bioinformatics Analyses of Differentially Expressed Genes Associated with Acute Myocardial Infarction Cardiovasc Ther 2016 34: 67-75
16329997 Ria M et al.: Human genetic evidence that OX40 is implicated in myocardial infarction Biochem. Biophys. Res. Commun. 2006 339: 1001-1006
10198196 Hao J et al.: Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing J. Mol. Cell. Cardiol. 1999 31: 667-678
17918316 Fischer P et al.: Survival pathways in hypertrophy and heart failure: the gp130-STAT axis Basic Res. Cardiol. 2007 102: 393-411
15034580 Bienengraeber M et al.: ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating Nat. Genet. 2004 36: 382-387
12684057 Chandrasekar B et al.: TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation. Biochem. Biophys. Res. Commun. 2003 303: 1152-1158
11742806 Sala R et al.: Two-way arginine transport in human endothelial cells: TNF-alpha stimulation is restricted to system y(+) Am. J. Physiol. 2002 282: C134-C143
20869944 Cortes VF et al.: Regulatory phosphorylation of FXYD2 by PKC and cross interactions between FXYD2, plasmalemmal Ca-ATPase and Na,K-ATPase Arch. Biochem. Biophys. 2011 505: 75-82
23785175 Obradovic M et al.: Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases J. Endocrinol. 2013 218: R13-R23
20064394 Lu Y et al.: The ion channel ASIC2 is required for baroreceptor and autonomic control of the circulation Neuron 2009 64: 885-897
18156197 Bray MS et al.: Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression Am. J. Physiol. Heart Circ. Physiol. 2008 294
22949532 Bannister JP et al.: Transcriptional upregulation of alpha2delta-1 elevates arterial smooth muscle cell voltage-dependent Ca2+ channel surface expression and cerebrovascular constriction in genetic hypertension Hypertension 2012 60: 1006-1015
21383000 Templin C et al.: Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6) Eur. Heart J. 2011 32: 1077-1088
19584346 Vasan RS et al.: Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data JAMA 2009 302: 168-178
8099908 Tang S et al.: Molecular localization of ion selectivity sites within the pore of a human L-type cardiac calcium channel J. Biol. Chem. 1993 268
11309420 Bang ML et al.: Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies J. Cell Biol. 2001 153: 413-427
12840750 Takeda S et al.: Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form Nature 2003 424: 35-41
10987068 Sanger JW et al.: Assembly of myofibrils in cardiac muscle cells Adv. Exp. Med. Biol. 2000 481: 89-102
25217174 Lodder EM et al.: An Integrative Genomic Approach Identifies Multiple Genes Involved in Cardiac Collagen Deposition
12358155 Jiang LQ et al.: Screening the proteins that interact with calpain in a human heart cDNA library using a yeast two-hybrid system Hypertens. Res. 2002 25: 647-652
12202917 Brown LJ et al.: Functional and spectroscopic studies of a familial hypertrophic cardiomyopathy mutation in Motif X of cardiac myosin binding protein-C Eur. Biophys. J. 2002 31: 400-408
14676215 Bullard B et al.: Association of the chaperone alphaB-crystallin with titin in heart muscle J. Biol. Chem. 2004 279: 7917-7924
11997265 Sadeghi A et al.: Regulation of the cardiac L-type Ca2+ channel by the actin-binding proteins alpha-actinin and dystrophin Am. J. Physiol. 2002 282
19850579 Mearini G et al.: Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms Cardiovasc. Res. 2010 85: 357-366
11927605 McElhinny AS et al.: Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 J. Cell Biol. 2002 157: 125-136
18782775 Cunha SR et al.: Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line J. Biol. Chem. 2008 283
18849322 Krishnan J et al.: Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function Circ. Res. 2008 103: 1139-1146
16407297 McGrath MJ et al.: Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly J. Biol. Chem. 2006 281: 7666-7683
19679835 Granzier HL et al.: Truncation of titins elastic PEVK region leads to cardiomyopathy with diastolic dysfunction Circ. Res. 2009 105: 557-564
23487791 Nam YJ et al.: Reprogramming of human fibroblasts toward a cardiac fate Proc. Natl. Acad. Sci. U.S.A. 2013 110: 5588-5593
10830164 Marx SO et al.: PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 2000 101: 365-376
23040497 Nyegaard M et al.: Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death Am. J. Hum. Genet. 2012 91: 703-712
11178895 Amodeo P et al.: Kinase recognition by calmodulin: modeling the interaction with the autoinhibitory region of human cardiac titin kinase J. Mol. Biol. 2001 306: 81-95
22522929 Qian L et al.: In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes Nature 2012 485: 593-598
23996002 Lin C et al.: Cypher/ZASP is a novel A-kinase anchoring protein J. Biol. Chem. 2013 288
17189427 Laustsen PG et al.: Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function Mol. Cell. Biol. 2007 27: 1649-1664
17060380 Vatta M et al.: Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome Circulation 2006 114: 2104-2112
22879586 Guo J et al.: Cell surface expression of human ether-a-go-go-related gene (hERG) channels is regulated by caveolin-3 protein via the ubiquitin ligase Nedd4-2 J. Biol. Chem. 2012 287
2584239 Noland TA Jr et al.: Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites J. Biol. Chem. 1989 264
9346285 Keane NE et al.: The ordered phosphorylation of cardiac troponin I by the cAMP-dependent protein kinase--structural consequences and functional implications Eur. J. Biochem. 1997 248: 329-337
11101505 Tinel N et al.: KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel EMBO J. 2000 19: 6326-6330
9230439 McDonald TV et al.: A minK-HERG complex regulates the cardiac potassium current I(Kr) Nature 1997 388: 289-292
17592081 Medeiros-Domingo A et al.: SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome Circulation 2007 116: 134-142
18184654 Wu L et al.: Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5 J. Biol. Chem. 2008 283: 6968-6978
21257757 Frank D et al.: Cardiac Z-disc signaling network J. Biol. Chem. 2011 286: 9897-9904
24202214 Suzuki Y et al.: Caveolin-1 facilitates the direct coupling between large conductance Ca2+-activated K+ (BKCa) and Cav1.2 Ca2+ channels and their clustering to regulate membrane excitability in vascular myocytes J. Biol. Chem. 2013 288
10567342 Bunemann M et al.: Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the beta(2) subunit J. Biol. Chem. 1999 274
23311301 Bosman A et al.: Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells Stem Cells Dev. 2013 22: 1717-1727
24375547 Du Y et al.: Lentiviral-mediated overexpression of Akt1 reduces anoxia-reoxygenation injury in cardiomyocytes Cell Biol. Int. 2014 38: 488-496
12039794 Hardt SE et al.: Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development Circ. Res. 2002 90: 1055-1063
25888601 Cieslik KA et al.: Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart FASEB J. 2015 29: 3160-3170
17242280 Oceandy D et al.: Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b Circulation 2007 115: 483-492
16701909 Phrommintikul A et al.: Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death Int. J. Cardiol. 2006 112: 142-152
12673799 Wehrens XH et al.: A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating Hum. Mutat. 2003 21: 552
19556521 Liu Q et al.: Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach Circ. Res. 2009 105: 194-200
15339904 Kang Y et al.: Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A J. Biol. Chem. 2004 279
14642002 Ning L et al.: Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome Genet. Test. 2003 7: 249-253
25171807 Smolina N et al.: Aggregate-prone desmin mutations impair mitochondrial calcium uptake in primary myotubes Cell Calcium 2014 56: 269-275
19022376 Muchir A et al.: Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells Biochim. Biophys. Acta 2009 1792: 75-81
19997769 Wheeler MA et al.: Identification of an emerin-beta-catenin complex in the heart important for intercalated disc architecture and beta-catenin localisation Cell. Mol. Life Sci. 2010 67: 781-796
17673255 Qu J et al.: Cardiac-specific haploinsufficiency of beta-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction J. Mol. Cell. Cardiol. 2007 43: 319-326
11807557 Tan HL et al.: A calcium sensor in the sodium channel modulates cardiac excitability Nature 2002 415: 442-447
17098824 Sekiguchi K et al.: Inhibition of PPAR-alpha activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3 Am. J. Physiol. Heart Circ. Physiol. 2007 292
23417040 Shaw RM et al.: L-type calcium channel targeting and local signalling in cardiac myocytes Cardiovasc. Res. 2013 98: 177-186
22666394 Traister A et al.: ILK induces cardiomyogenesis in the human heart PLoS ONE 2012 7
24454898 Zaveri HP et al.: Identification of critical regions and candidate genes for cardiovascular malformations and cardiomyopathy associated with deletions of chromosome 1p36 PLoS ONE 2014 9
23398819 Clarke SL et al.: Barth syndrome Orphanet J Rare Dis 2013 8: 23
20582536 Schwenk RW et al.: Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes Diabetologia 2010 53: 2209-2219
18719600 Carling D et al.: The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 2008 32: S55-S59
14614828 Woods A et al.: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade Curr. Biol. 2003 13: 2004-2008
22116099 Higashikuni Y et al.: The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response Arterioscler. Thromb. Vasc. Biol. 2012 32: 654-661
24530811 Tucci S et al.: Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice Biochim. Biophys. Acta 2014 1842: 677-685
18830417 Kerkela R et al.: Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation J. Clin. Invest. 2008 118: 3609-3618
22912742 Sysa-Shah P et al.: Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice PLoS ONE 2012 7
18502941 Dallabrida SM et al.: Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy FASEB J. 2008 22: 3010-3023
16374517 Peng X et al.: Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice J. Clin. Invest. 2006 116: 217-227
17261657 Peng J et al.: Cardiac hypertrophy and reduced contractility in hearts deficient in the titin kinase region Circulation 2007 115: 743-751
14982994 Pan Y et al.: Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics Proc. Natl. Acad. Sci. U.S.A. 2004 101: 2241-2246
23224875 Menick DR et al.: Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failure Adv. Exp. Med. Biol. 2013 961: 125-135
23044624 Chen AL et al.: Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy Braz. J. Med. Biol. Res. 2012 45: 1150-1156
17088456 Lu H et al.: Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice Circulation 2006 114: 2271-2279
14657064 Pepine CJ et al.: A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 2003 290: 2805-2816
21423583 Muendlein A et al.: Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis. PLoS ONE 2011 6
22643843 Perla-Kajan J et al.: Paraoxonase 1 and homocysteine metabolism Amino Acids 2012 43: 1405-1417
20173117 Shah SH et al.: Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events Circ Cardiovasc Genet 2010 3: 207-214
20686565 Teslovich TM et al.: Biological, clinical and population relevance of 95 loci for blood lipids Nature 2010 466: 707-713
24097068 Willer CJ et al.: Discovery and refinement of loci associated with lipid levels Nat. Genet. 2013 11: 1274-1283
16946132 Brunham LR et al.: Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels Circ. Res. 2006 99: 672-674
21733517 Jiang F et al.: Fine mapping of chromosome 3q22.3 identifies two haplotype blocks in ESYT3 associated with coronary artery disease in female Han Chinese Atherosclerosis 2011 218: 397-403
24704371 Wang Z et al.: Epigenetic upregulation of PSD-95 contributes to the rewarding behavior by morphine conditioning Eur. J. Pharmacol. 2014 732: 123-129
23701246 Bian W et al.: Stabilization of the angiotensin-(1-7) receptor Mas through interaction with PSD95 Biochem. J. 2013 453: 345-356
23664202 Dohi T et al.: Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome Atherosclerosis 2013 229: 192-197
18192653 Nagle CA et al.: Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6-/- mice J. Lipid Res. 2008 49: 823-831
18927507 Kamagate A et al.: FoxO1 integrates insulin signaling to VLDL production. Cell Cycle 2008 7: 3162-3170
18439917 Zhang C et al.: Role of NonO-histone interaction in TNFalpha-suppressed prolyl-4-hydroxylase alpha1. Biochim. Biophys. Acta 2008 1783: 1517-1528
15472203 Dandona P et al.: Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin J. Clin. Endocrinol. Metab. 2004 89: 5043-5047
8901609 Velloso LA et al.: Cross-talk between the insulin and angiotensin signaling systems Proc. Natl. Acad. Sci. U.S.A. 1996 93
20228403 McMurray JJ et al.: Effect of valsartan on the incidence of diabetes and cardiovascular events N. Engl. J. Med. 2010 362: 1477-1490
22134503 Ringseis R et al.: Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency Eur J Nutr 2012 1: 1-18
22833659 Clifford AJ et al.: Gender and single nucleotide polymorphisms in MTHFR, BHMT, SPTLC1, CRBP2, CETP, and SCARB1 are significant predictors of plasma homocysteine normalized by RBC folate in healthy adults J. Nutr. 2012 142: 1764-1771
21436600 Kiso Y et al.: Pharmacology in health foods: effects of arachidonic acid and docosahexaenoic acid on the age-related decline in brain and cardiovascular system function J. Pharmacol. Sci. 2011 115: 471-475
23553151 Curtis PJ et al.: Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial Am. J. Clin. Nutr. 2013 97: 936-942
22250063 Curtis PJ et al.: Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial Diabetes Care 2012 35: 226-232
21733722 Innes KE et al.: Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review Sleep Med Rev 2012 4: 309-339
17374715 Lu G et al.: A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development Genes Dev. 2007 21: 784-796
8560269 Acton S et al.: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor Science 1996 271: 518-520
18947868 Dally S et al.: Compartmentalized expression of three novel sarco/endoplasmic reticulum Ca2+ATPase 3 isoforms including the switch to ER stress, SERCA3f, in non-failing and failing human heart Cell Calcium 2009 45: 144-154
21965681 Mohamed TM et al.: Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain J. Biol. Chem. 2011 286
12933703 Gros R et al.: Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure Circ. Res. 2003 93: 614-621
18221109 Ochi R et al.: Ryanodine receptor: a novel therapeutic target in heart disease Recent Pat Cardiovasc Drug Discov 2007 2: 110-118
16580578 El Midaoui A et al.: Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats Am. J. Hypertens. 2006 19: 407-412
16580578 El Midaoui A et al.: Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats Am. J. Hypertens. 2006 19: 407-412
20302927 Blanquicett C et al.: Oxidative stress modulates PPAR gamma in vascular endothelial cells Free Radic. Biol. Med. 2010 48: 1618-1625
23844512 author information missing [To the mechanisms of antiarrhythmic action of Allapinine] Bioorg. Khim. 2013 39: 105-116
22078798 Choi JH et al.: Flt3 signaling-dependent dendritic cells protect against atherosclerosis Immunity 2011 35: 819-831
18276926 Duan SZ et al.: Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature Circ. Res. 2008 102: 283-294
10073956 Marx N et al.: PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease Arterioscler. Thromb. Vasc. Biol. 1999 19: 546-551
24113457 Alzoubi A et al.: TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension Am. J. Pathol. 2013 183: 1779-1788
9422509 Jiang C et al.: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 1998 391: 82-86
10843708 Marx N et al.: Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells J. Immunol. 2000 164: 6503-6508
10512746 Chen NG et al.: PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression Biochem. Biophys. Res. Commun. 1999 263: 718-722
10645917 Pasceri V et al.: Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators Circulation 2000 101: 235-238
10479650 Jackson SM et al.: Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction Arterioscler. Thromb. Vasc. Biol. 1999 19: 2094-2104
15694007 Sasaki M et al.: Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha BMC Physiol. 2005 5: 3
15117825 Verrier E et al.: PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase Circ. Res. 2004 94: 1515-1522
23150690 Karakas M et al.: Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study J. Clin. Endocrinol. Metab. 2013 98: 272-280
24215469 Then C et al.: Plasma Copeptin levels are inversely associated with Intima-Media-Thickness in Men: the Population-based KORA F4 Study Cardiovasc Diabetol 2013 12: 168
16614755 Mergia E et al.: Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system J. Clin. Invest. 2006 116: 1731-1737
9769303 Nagai Y et al.: Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia Circulation 1998 98: 1504-1509
7510950 Knowles RG et al.: Nitric oxide synthases in mammals Biochem. J. 1994 298: 249-258
3131684 Palmer RM et al.: Vascular endothelial cells synthesize nitric oxide from L-arginine Nature 1988 333: 664-666
11509489 Taddei S et al.: Age-related reduction of NO availability and oxidative stress in humans Hypertension 2001 38: 274-279
9631871 Taddei S et al.: Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension Circulation 1998 97: 2222-2229
10906340 Reiter CD et al.: Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite J. Biol. Chem. 2000 275
9187601 Kooy NW et al.: Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite Crit. Care Med. 1997 25: 812-819
8342632 Brady AJ et al.: Nitric oxide attenuates cardiac myocyte contraction Am. J. Physiol. 1993 265: H176-H182
7536096 Schulz R et al.: The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha Br. J. Pharmacol. 1995 114: 27-34
24004504 Choe CU et al.: Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies Circulation 2013 128: 1451-1461
23980179 Yang J et al.: Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity Proc. Natl. Acad. Sci. U.S.A. 2013 110
22301267 Chen J et al.: C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products Gene 2012 496: 128-135
12922018 Mineo C et al.: HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action Trends Cardiovasc. Med. 2003 13: 226-231
9506985 Wong JT et al.: Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells J. Biol. Chem. 1998 273: 6830-6836
23969698 DiDonato JA et al.: Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma Circulation 2013 128: 1644-1655
10764676 Pilon A et al.: Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake Arterioscler. Thromb. Vasc. Biol. 2000 20: 1074-1081
15113749 Herrera M et al.: Endothelin stimulates endothelial nitric oxide synthase expression in the thick ascending limb Am. J. Physiol. Renal Physiol. 2004 287: F231-F235
10519149 Marsen TA et al.: Tyrosine-kinase-dependent regulation of the nitric oxide synthase gene by endothelin-1 in human endothelial cells Pflugers Arch. 1999 438: 538-544
11376172 Tzourio C et al.: Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism Neurology 2001 56: 1273-1277
21139021 Cindrova-Davies T et al.: Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling Cardiovasc. Res. 2011 89: 671-679
21273556 Cole LK et al.: Impaired phosphatidylcholine biosynthesis reduces atherosclerosis and prevents lipotoxic cardiac dysfunction in ApoE-/- Mice Circ. Res. 2011 108: 686-694
22282588 Li F et al.: eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype J. Am. Soc. Nephrol. 2012 23: 652-660
11086993 Fang M et al.: Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON Neuron 2000 28: 183-193
22499993 Goncalves I et al.: Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation Arterioscler. Thromb. Vasc. Biol. 2012 32: 1505-1512
14616768 Benjafield AV et al.: Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension Clin. Genet. 2003 64: 433-438
8126072 Goligorsky MS et al.: Termination of endothelin signaling: role of nitric oxide J. Cell. Physiol. 1994 158: 485-494
2153712 Boulanger C et al.: Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide J. Clin. Invest. 1990 85: 587-590
9396733 Schweizer A et al.: Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations Biochem. J. 1997 328: 871-877
7672512 Pollock DM et al.: Endothelin receptors and calcium signaling FASEB J. 1995 9: 1196-1204
7526714 McQuillan LP et al.: Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms Am. J. Physiol. 1994 267
16908409 Cheah JH et al.: NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1 Neuron 2006 51: 431-440
9931481 Phung YT et al.: Both neuronal NO synthase and nitric oxide are required for PC12 cell differentiation: a cGMP independent pathway Brain Res. Mol. Brain Res. 1999 64: 165-178
9449433 Dong-Ryul L et al.: Stimulation of NGF production by tryptophan and its metabolites in cultured mouse astroglial cells Brain Res. 1997 777: 228-230
21909115 Ehret GB et al.: Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk Nature 2011 478: 103-109
22024276 Dohi T et al.: Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome Atherosclerosis 2011 219: 907-912
2782444 Vikenes K et al.: Serotonin is associated with coronary artery disease and cardiac events Circulation 1999 100: 483-489
19191108 Breard M et al.: Serotonin binds to purified neuronal nitric oxide synthase: a possible explanation for ROS production induced by 5HT in the presence of nNOS Free Radic. Res. 2009 43: 206-213
23967253 Fernandez C et al.: Plasma lipid composition and risk of developing cardiovascular disease PLoS ONE 2013 8
17454123 Breard M et al.: The endogenous neurotransmitter, serotonin, modifies neuronal nitric oxide synthase activities Free Radic. Res. 2007 41: 413-423
24170240 Liu H et al.: Acute tryptophan depletion reduces nitric oxide synthase in the rat hippocampus Neurochem. Res. 2013 38: 2595-2603
15572052 Fujita M et al.: Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts J. Mol. Cell. Cardiol. 2004 37: 1219-1223
9205947 Spitsin SV et al.: Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-kappa B Mol. Med. 1997 3: 315-326
21983165 Dohi T et al.: Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome Clin. Chim. Acta 2012 413: 207-212
9443438 Wever RM et al.: Atherosclerosis and the two faces of endothelial nitric oxide synthase Circulation 1998 1: 108-112
24444440 Zhang Y et al.: Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries Eur. J. Pharmacol. 2014 725: 10-17
22659061 Ferreira PF et al.: Oxidized low-density lipoproteins and their antibodies: relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases Clin. Chim. Acta 2012 413: 1472-1478
12372822 van Haperen R et al.: Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein J. Biol. Chem. 2002 277
16554055 Siggins S et al.: Altered hepatic lipid status and apolipoprotein A-I metabolism in mice lacking phospholipid transfer protein Atherosclerosis 2007 190: 114-123
20642808 Linkous A et al.: Cytosolic phospholipase A2 as a mediator of disease pathogenesis Cell. Microbiol. 2010 12: 1369-1377
10079112 Jiang XC et al.: Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels J. Clin. Invest. 1999 103: 907-914
24292666 Zhang Y et al.: Protective effect of phosphatidylcholine on restoration of ethanol-injured hepatocytes related with caveolin-1 J. Membr. Biol. 2014 1: 73-80
15694928 Stein O et al.: Lipid transfer proteins (LTP) and atherosclerosis Atherosclerosis 2005 178: 217-230
19815546 Yea K et al.: Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes J. Biol. Chem. 2009 284
21291330 Kinney GL et al.: Lipoprotein-associated phospholipase A(2) activity predicts progression of subclinical coronary atherosclerosis Diabetes Technol. Ther. 2011 13: 381-387
14636062 Zhao Y et al.: Negative charge at amino acid 149 is the molecular determinant for substrate specificity of lecithin: cholesterol acyltransferase for phosphatidylcholine containing 20-carbon sn-2 fatty acyl chains Biochemistry 2003 42
20018880 Butler PL et al.: Cross-talk between remodeling and de novo pathways maintains phospholipid balance through ubiquitination J. Biol. Chem. 2010 285: 6246-6258
20610733 Riederer M et al.: Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production J. Lipid Res. 2010 51: 2957-2966
11719520 Furbee JW Jr et al.: Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice J. Biol. Chem. 2002 277: 3511-3519
21875686 Tietjen I et al.: Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT Biochim. Biophys. Acta 2012 1821: 416-424
22848500 Barber MN et al.: Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes PLoS ONE 2012 7
15721011 Rosenblat M et al.: Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine Atherosclerosis 2005 1: 69-77
12615663 Rozenberg O et al.: Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation Arterioscler. Thromb. Vasc. Biol. 2003 23: 461-467
15454271 Aviram M et al.: Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development Free Radic. Biol. Med. 2004 37: 1304-1316
12052468 Yamamoto M et al.: The expression of extracellular-superoxide dismutase is increased by lysophosphatidylcholine in human monocytic U937 cells Atherosclerosis 2002 163: 223-228
9614091 Cieslik K et al.: Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine J. Biol. Chem. 1998 273
7657841 Zembowicz A et al.: Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine J. Clin. Invest. 1995 96: 1688-1692
12814390 Wirleitner B et al.: Immune activation and degradation of tryptophan in coronary heart disease Eur. J. Clin. Invest. 2003 33: 550-554
23741477 Rao SP et al.: Acyl chain-dependent effect of lysophosphatidylcholine on endothelium-dependent vasorelaxation PLoS ONE 2013 8
23336953 Sulo G et al.: Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study Int. J. Cardiol. 2013 168: 1435-1440
6429267 author information missing Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma J. Exp. Med. 1984 160: 310-316
6165986 author information missing Induction of pulmonary indoleamine 2,3-dioxygenase by interferon Proc. Natl. Acad. Sci. U.S.A. 1981 78: 129-132
8910295 Garcia-Cardena G et al.: Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1 J. Biol. Chem. 1996 271
11028854 Ryborg AK et al.: Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes Acta Derm. Venereol. 2000 80: 242-246
17502572 Lavi S et al.: Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans Circulation 2007 115: 2715-2721
12809603 Lauber K et al.: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal Cell 2003 113: 717-730
8643658 Moro MA et al.: cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase Proc. Natl. Acad. Sci. U.S.A. 1996 93: 1480-1485
8573563 Stone JR et al.: Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide Biochemistry 1996 35: 1093-1099
15728511 Lin P et al.: Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP J. Immunol. 2005 174: 2981-2989
7955906 Bode-Boger SM et al.: L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects Clin. Sci. 1994 87: 303-310
8616947 Bode-Boger SM et al.: L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study Circulation 1996 93: 85-90
9024155 Adams MR et al.: L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules Circulation 1997 95: 662-668
19465644 Ponnuswamy P et al.: Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase Am. J. Pathol. 2009 174: 2400-2410
12655043 Lee J et al.: Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox Proc. Natl. Acad. Sci. U.S.A. 2003 100: 4843-4848
10880973 Malle E et al.: Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins Eur. J. Biochem. 2000 267: 4495-4503
12524231 Chen J et al.: Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice Arterioscler. Thromb. Vasc. Biol. 2003 1: 97-103
10975863 Detmers PA et al.: Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice J. Immunol. 2000 165: 3430-3435
9833603 Bode-Boger SM et al.: L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship Br J Clin Pharmacol 1998 46: 489-497
8900200 Yuan Y et al.: The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase J. Biol. Chem. 1996 271
23890667 Davids M et al.: Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells Metab. Clin. Exp. 2013 62: 1455-1461
8692835 Garcia-Cardena G et al.: Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling Proc. Natl. Acad. Sci. U.S.A. 1996 93: 6448-6453
17893196 Murata T et al.: Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice J. Exp. Med. 2007 204: 2373-2382
9325253 Garcia-Cardena G et al.: Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo J. Biol. Chem. 1997 272
9820828 Okajima F et al.: Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells Biochem. J. 1998 336: 491-500
24353182 Cassuto J et al.: Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients Diabetes 2014 63: 1381-1393
10325239 Vila-Petroff MG et al.: Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes Circ. Res. 1999 84: 1020-1031
22070693 Fuchs B et al.: Lysophospholipids: potential markers of diseases and infertility? }, authors { names std { { name ml Fuchs B, affil str Institute of Medical Physics and Biophysics, University of Leipzig, Leipzig, Germany Mini Rev Med Chem 2012 12: 74-86
21339854 Ford DA et al.: Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia Clin Lipidol 2010 5: 835-852
11238037 Sugiyama S et al.: Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes Am. J. Pathol. 2001 158: 879-891
15292228 Pennathur S et al.: Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species J. Biol. Chem. 2004 279
15314690 Zheng L et al.: Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease J. Clin. Invest. 2004 114: 529-541
14638540 Thukkani AK et al.: Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 2003 108: 3128-3133
15514213 Marsche G et al.: 2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis Arterioscler. Thromb. Vasc. Biol. 2004 24: 2302-2306
18493808 Messner MC et al.: 2-Chlorohexadecanal and 2-chlorohexadecanoic acid induce COX-2 expression in human coronary artery endothelial cells Lipids 2008 43: 581-588
22632920 Gungor Z et al.: Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk Atherosclerosis 2012 223: 230-234
18703020 Tsubakio-Yamamoto K et al.: Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages Biochem. Biophys. Res. Commun. 2008 375: 390-394
22064597 Miyazaki T et al.: m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis Circulation 2011 124: 2522-2532
12824289 Stalker TJ et al.: A novel role for calpains in the endothelial dysfunction of hyperglycemia FASEB J. 2003 17: 1511-1513
9580552 Garcia-Cardena G et al.: Dynamic activation of endothelial nitric oxide synthase by Hsp90 Nature 1998 392: 821-824
22984960 Song G et al.: SR-BI associates with ABCG1 and inhibits ABCG1-mediated cholesterol efflux from cells to high-density lipoprotein 3 Lipids Health Dis 2012 11: 118
12588762 Chaudhuri P et al.: Lysophosphatidylcholine inhibits endothelial cell migration by increasing intracellular calcium and activating calpain Arterioscler. Thromb. Vasc. Biol. 2003 23: 218-223
16456089 Van Eck M et al.: Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice Arterioscler. Thromb. Vasc. Biol. 2006 26: 929-934
18057374 Catalano G et al.: Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects J. Lipid Res. 2008 3: 635-643
20562425 Feng Y et al.: Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis Cardiovasc. Res. 2010 2: 376-385
21520072 Lin CY et al.: Endothelin-1 exacerbates lipid accumulation by increasing the protein degradation of the ATP-binding cassette transporter G1 in macrophages J. Cell. Physiol. 2011 226: 2198-2205
23720744 Tsukamoto K et al.: Noncanonical role of the PDZ4 domain of the adaptor protein PDZK1 in the regulation of the hepatic high density lipoprotein receptor scavenger receptor class B, type I (SR-BI) J. Biol. Chem. 2013 288
10829064 Ikemoto M et al.: Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I Proc. Natl. Acad. Sci. U.S.A. 2000 97: 6538-6543
24394674 Liu HY et al.: Imbalanced response of ATP-binding cassette transporter A1 and CD36 expression to increased oxidized low-density lipoprotein loading contributes to the development of THP-1 derived foam cells J. Biochem. 2014 155: 35-42
20075420 de la Llera-Moya M et al.: The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages Arterioscler. Thromb. Vasc. Biol. 2010 4: 796-801
9703956 Sawamura T et al.: An endothelial receptor for oxidized low-density lipoprotein Nature 1997 386: 73-77
10869259 Sawamura T et al.: An endothelial receptor for oxidized low-density lipoprotein Nature 1997 386: 73-77
19279231 Sawamura T et al.: An endothelial receptor for oxidized low-density lipoprotein Nature 1997 386: 73-77
9052782 Sawamura T et al.: An endothelial receptor for oxidized low-density lipoprotein Nature 1997 386: 73-77
9052782 author information missing article information missing
16061948 Asztalos BF et al.: Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux J. Lipid Res. 2005 46: 2246-2253
12130721 author information missing Denpasar Declaration on Population and Development Integration 1994 40: 27-29
10918065 Wang N et al.: Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1 J. Biol. Chem. 2000 275
11880569 Mardones P et al.: Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice J. Nutr. 2002 132: 443-449
10777555 author information missing article information missing
11433352 Yuhanna IS et al.: High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase Nat. Med. 2001 7: 853-857
12637341 author information missing article information missing
24713582 Fruhwurth S et al.: Inhibition of mTOR down-regulates scavenger receptor, class B, type I (SR-BI) expression, reduces endothelial cell migration and impairs nitric oxide production Biochim. Biophys. Acta 2014 1841: 944-953
9671306 Mach F et al.: Reduction of atherosclerosis in mice by inhibition of CD40 signalling Nature 1998 394: 200-203
21130456 Ryoo S et al.: OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling Atherosclerosis 2011 214: 279-287
16339487 Seetharam D et al.: High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I Circ. Res. 2006 98: 63-72
17008605 Ryoo S et al.: Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling Circ. Res. 2006 99: 951-960
7583580 Cockerill GW et al.: High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules Arterioscler. Thromb. Vasc. Biol. 1995 15: 1987-1994
10753938 Uittenbogaard A et al.: High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae J. Biol. Chem. 2000 275
10542298 Blair A et al.: Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation J. Biol. Chem. 1999 274
15838273 Sakurai K et al.: Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1) J. Cardiovasc. Pharmacol. 2004 44: S173-S180
12504834 Li D et al.: Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells Cardiovasc. Res. 2003 57: 238-243
24384558 Chou HC et al.: 5-Methoxytryptophan-dependent protection of cardiomyocytes from heart ischemia reperfusion injury Arch. Biochem. Biophys. 2014 543: 15-22
22851770 Cheng HH et al.: Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan Proc. Natl. Acad. Sci. U.S.A. 2012 109
14684629 Chen J et al.: Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells Circ. Res. 2004 94: 370-376
12419941 Imanishi T et al.: Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells Circ. J. 2002 66: 1060-1064
17433786 Chen XP et al.: Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species Vascul. Pharmacol. 2007 47: 1-9
20203069 Ou HC et al.: EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling J. Appl. Physiol. 2010 108: 1745-1756
23990020 Adlakha YK et al.: Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRalpha expression and cholesterol homeostasis Cell Death Dis 2013 4: e780
2443564 Carlin JM et al.: Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures J. Immunol. 1987 139: 2414-2418
17349013 Pertovaara M et al.: Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study Clin. Exp. Immunol. 2007 148: 106-111
18390905 Thum T et al.: LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium J. Biol. Chem. 2008 283
13678429 Robinson CM et al.: Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha J. Interferon Cytokine Res. 2003 23: 413-421
16173915 Chen J et al.: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis Biochem. J. 2006 393: 255-265
12566375 Li D et al.: LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells Circulation 2003 107: 612-617
8663541 Chon SY et al.: Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene J. Biol. Chem. 1996 271
21359968 Jackman KA et al.: Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice Naunyn Schmiedebergs Arch. Pharmacol. 2011 383: 471-481
20190767 Wang Y et al.: Kynurenine is an endothelium-derived relaxing factor produced during inflammation Nat. Med. 2010 16: 279-285
8067435 Williams SP et al.: Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle Am. J. Physiol. 1994 267: H796-H803
19932078 Sun J et al.: Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production Arch. Biochem. Biophys. 2010 494: 130-137
12697739 Landmesser U et al.: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J. Clin. Invest. 2003 111: 1201-1209
19767531 Yang YM et al.: eNOS uncoupling and endothelial dysfunction in aged vessels Am. J. Physiol. Heart Circ. Physiol. 2009 297
20375905 Hung MJ et al.: Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells J. Hypertens. 2010 28: 940-951
7542654 Zembowicz A et al.: Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine J. Biol. Chem. 1995 270
15265762 Li J et al.: Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle Am. J. Physiol. Endocrinol. Metab. 2004 287: E834-E841
11278602 Nicholson B et al.: Sustained nitric oxide production in macrophages requires the arginine transporter CAT2 J. Biol. Chem. 2001 276
16158068 Gluais P et al.: Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin Br. J. Pharmacol. 2005 146: 834-845
8770859 Zeng G et al.: Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells J. Clin. Invest. 1996 98: 894-898
23306778 Muniyappa R et al.: Role of insulin resistance in endothelial dysfunction Rev Endocr Metab Disord 2013 14: 5-12
17666490 Lira VA et al.: Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle Am. J. Physiol. Endocrinol. Metab. 2007 293
23863813 Wang H et al.: Nitric oxide directly promotes vascular endothelial insulin transport Diabetes 2013 62: 4030-4042
9101435 Chen L et al.: Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation J. Lipid Res. 1997 38: 546-553
7543827 Pritchard KA Jr et al.: Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion Circ. Res. 1995 77: 510-518
11004212 Heinloth A et al.: Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells J. Am. Soc. Nephrol. 2000 11: 1819-1825
11914250 Sorescu D et al.: Superoxide production and expression of nox family proteins in human atherosclerosis Circulation 2002 105: 1429-1435
20639222 Dikalova AE et al.: Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling Am. J. Physiol. Heart Circ. Physiol. 2010 299: H673-H679
11872373 Hashimoto T et al.: Lysophosphatidylcholine inhibits the expression of prostacyclin stimulating factor in cultured vascular smooth muscle cells J. Diabetes Complicat. 2002 16: 81-86
9498645 Ono Y et al.: Effect of high glucose concentrations on prostacyclin-stimulating factor mRNA expression in cultured aortic smooth muscle cells Diabetologia 1998 41: 134-140
11078463 Inoguchi T et al.: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 2000 49: 1939-1945
23466300 Lee EK et al.: Betaine attenuates lysophosphatidylcholine-mediated adhesion molecules in aged rat aorta: modulation of the nuclear factor-kappaB pathway Exp. Gerontol. 2013 48: 517-524
14729074 Zhu Y et al.: Low density lipoprotein induces eNOS translocation to membrane caveolae: the role of RhoA activation and stress fiber formation Biochim. Biophys. Acta 2003 1635: 117-126
19135546 Zhou Q et al.: High-dose lovastatin decreased basal prostacyclin production in cultured endothelial cells Prostaglandins Other Lipid Mediat. 2009 89: 1-7
21402147 Crabtree MJ et al.: Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency Free Radic. Biol. Med. 2011 50: 1639-1646
17350631 Iwase M et al.: Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment Atherosclerosis 2008 196: 931-936
14599292 Wei J et al.: Peroxide-mediated chromatin remodelling of a nuclear factor kappa B site in the mouse inducible nitric oxide synthase promoter Biochem. J. 2004 377: 809-818
15194459 Hattori Y et al.: NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO Cardiovasc. Res. 2004 63: 31-40
15743275 Li C et al.: Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport Biochem. J. 2005 386: 567-574
18309100 Ryoo S et al.: Endothelial arginase II: a novel target for the treatment of atherosclerosis Circ. Res. 2008 102: 923-932
21625171 Dioguardi FS et al.: To give or not to give? Lessons from the arginine paradox J Nutrigenet Nutrigenomics 2011 4: 90-98
16723138 de Castro Barbosa T et al.: Chronic oral administration of arginine induces GH gene expression and insulin resistance Life Sci. 2006 15: 1444-1449
24914683 Kalogeris TJ et al.: Adenosine prevents TNFalpha-induced decrease in endothelial mitochondrial mass via activation of eNOS-PGC-1alpha regulatory axis PLoS ONE 2014 6
24841857 Qin X et al.: Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation Cell. Immunol. 2014 289: 185-190
21159337 Brocheriou I et al.: Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis Atherosclerosis 2011 214: 316-324
25066694 Siu KL et al.: Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS
19544385 Venardos KM et al.: Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury J. Cell. Biochem. 2009 108: 156-168
23011059 Luiking YC et al.: Arginine de novo and nitric oxide production in disease states Am. J. Physiol. Endocrinol. Metab. 2012 303
24929284 Borrell-Pages M et al.: Cholesterol modulates LRP5 expression in the vessel wall Atherosclerosis 2014 2: 363-370
25296984 Hodgkinson CP et al.: Abi3bp regulates cardiac progenitor cell proliferation and differentiation Circ. Res. 2014 115: 1007-1016
11739276 Xiao G et al.: Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis Circ. Res. 2001 89: 1122-1129
26517696 author information missing Endothelial-to-mesenchymal transition drives atherosclerosis progression J. Clin. Invest. 2015 125: 4514-4528
17442284 Yang HY et al.: Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice Cardiovasc. Res. 2007 75: 139-147
15234972 Wu BT et al.: A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones J. Biol. Chem. 2004 279
16735509 Williams JC et al.: The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex J. Biol. Chem. 2006 281
19074137 Deevska GM et al.: Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice J. Biol. Chem. 2009 284: 8359-8368
19478200 Verschuren L et al.: MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease Circ. Res. 2009 105: 99-107
20134099 Mandosi E et al.: Atorvastatin downregulates monocyte CD36 expression, nuclear NFkappaB and TNFalpha levels in type 2 diabetes J. Atheroscler. Thromb. 2010 17: 539-545
10400004 Kawano H et al.: Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J. Am. Coll. Cardiol. 1999 34: 146-154
19679829 Westmuckett AD et al.: Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice Arterioscler. Thromb. Vasc. Biol. 2009 29: 1730-1736
23185679 Munch G et al.: Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits Heart Int 2012 7: E12
23628701 Hu FY et al.: AGGF1 is a novel anti-inflammatory factor associated with TNF-alpha-induced endothelial activation Cell. Signal. 2013 25: 1645-1653
16244876 author information missing Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels J. Mol. Med. 2005 83: 865-875
24675658 Kuijpers MJ et al.: Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen Arterioscler. Thromb. Vasc. Biol. 2014 34: 1187-1192
26493158 Chistiakov DA et al.: Macrophage-mediated cholesterol handling in atherosclerosis J. Cell. Mol. Med. 2016 1: 17-28
20411357 Wu SB et al.: Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome. Mol. Neurobiol. 2010 41: 256-266
25559684 Catteruccia M et al.: Myo-cardiomyopathy is commonly associated with the A8344G MERRF mutation J. Neurol. 2015 262: 701-710
18587274 Choi BO et al.: A MELAS syndrome family harboring two mutations in mitochondrial genome Exp. Mol. Med. 2008 40: 354-360
15767514 Naini AB et al.: Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF Arch. Neurol. 2005 62: 473-476
22285193 Gui C et al.: Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy Cardiovasc. Pathol. 2012 21: 414-420
22524197 Zhang Y et al.: Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3beta and mitochondrial function BMC Med 2012 10: 40
20184888 Kruger M et al.: Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy J. Mol. Cell. Cardiol. 2010 48: 910-916
19367030 Sung PH et al.: Impact of hyperglycemic control on left ventricular myocardium. A molecular and cellular basic study in a diabetic rat model Int Heart J 2009 50: 191-206
17178726 Oestreich EA et al.: Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes J. Biol. Chem. 2007 282: 5488-5495
10805403 Simko F et al.: The potential role of nitric oxide in the hypertrophic growth of the left ventricle Physiol Res 2000 49: 37-46
15931622 Ouslimani N et al.: Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells Metab. Clin. Exp. 2005 54: 829-834
17292717 Ouslimani N et al.: Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1 Metab. Clin. Exp. 2007 56: 308-313
18177481 Zou MH et al.: AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function Clin. Exp. Pharmacol. Physiol. 2008 35: 535-545
27230643 Shah MS et al.: Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes Circ. Res. 2016 118: 1808-1829
15657614 Blakely EL et al.: LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation Eur. J. Hum. Genet. 2005 13: 623-627
26095523 El-Hattab AW et al.: MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options Mol. Genet. Metab. 2015 116: 4-12
19188198 Ware SM et al.: Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes J. Med. Genet. 2009 46: 308-314
17954552 Jonckheere AI et al.: A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy J. Med. Genet. 2008 45: 129-133
18089699 Langeveld M et al.: Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance J. Clin. Endocrinol. Metab. 2008 93: 845-851
23266198 Yap TL et al.: Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity Mol. Genet. Metab. 2013 108: 56-64
22337770 Jovic M et al.: Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, beta-glucocerebrosidase Mol. Biol. Cell 2012 23: 1533-1545
22659419 Harzer K et al.: Beta-glucosidase 1 (GBA1) is a second bile acid beta-glucosidase in addition to beta-glucosidase 2 (GBA2). Study in beta-glucosidase deficient mice and humans Biochem. Biophys. Res. Commun. 2012 423: 308-312
15855349 Hearn T et al.: Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes Diabetes 2005 54: 1581-1587
25299671 Favaretto F et al.: GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance PLoS ONE 2014 9
22459206 Fletcher AL et al.: Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies Mol. Genet. Metab. 2012 106: 18-24
27078015 Yonekawa Y et al.: Ultra-Wide-Field Autofluorescence in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Chorioretinopathy JAMA Ophthalmol 2016 134
23430524 Haglind CB et al.: Growth in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency JIMD Rep 2013 8: 81-90
23395167 Singh R et al.: LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans Cell Metab. 2013 2: 197-209
26937387 Ravn K et al.: Neonatal mitochondrial hepatoencephalopathy caused by novel GFM1 mutations Mol Genet Metab Rep 2015 3: 5-10
21549344 Gotz A et al.: Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy Am. J. Hum. Genet. 2011 88: 635-642
23929671 Baruffini E et al.: MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast Hum. Mutat. 2013 34: 1501-1509
23849775 Haack TB et al.: ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy Am. J. Hum. Genet. 2013 93: 211-223
23315540 Carroll CJ et al.: Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy J. Med. Genet. 2013 50: 151-159
10446428 Ganesh Bhat B et al.: Rat sn-glycerol-3-phosphate acyltransferase: molecular cloning and characterization of the cDNA and expressed protein. Biochim. Biophys. Acta 1999 1439: 415-423
12417724 Hammond LE et al.: Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition Mol. Cell. Biol. 2002 22: 8204-8214
1721057 Shin DH et al.: Transcriptional regulation of p90 with sequence homology to Escherichia coli glycerol-3-phosphate acyltransferase. J. Biol. Chem. 1991 266
10051453 Muoio DM et al.: AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem. J. 1999 338: 783-791
598501 Bates EJ et al.: Acute effects of insulin on glycerol phosphate acyl transferase activity, ketogenesis and serum free fatty acid concentration in perfused rat liver. FEBS Lett. 1977 84: 225-228
598502 et al.: A selective decrease in mitochondrial glycerol phosphate acyltransferase activity in livers from streptozotocin-diabetic rats FEBS Lett. 1977 84: 229-232
518562 Bates EJ et al.: A study of the glycerol phosphate acyltransferase and dihydroxyacetone phosphate acyltransferase activities in rat liver mitochondrial and microsomal fractions. Relative distribution in parenchymal and non-parenchymal cells, effects of N-ethylmaleimide, palmitoyl-coenzyme A concentration, starvation, adrenalectomy and anti-insulin serum treatment. Biochem. J. 1979 182: 751-762
15280151 Ameen C et al.: Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver. Am. J. Physiol. Endocrinol. Metab. 2004 287
15878874 Hammond LE et al.: Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J. Biol. Chem. 2005 280
16054099 Neschen S et al.: Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2005 2: 55-65
16935266 Xu H et al.: Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile Biochem. Biophys. Res. Commun. 2006 349: 439-448
15778226 Onorato TM et al.: Phosphorylation of rat liver mitochondrial glycerol-3-phosphate acyltransferase by casein kinase 2 J. Biol. Chem. 2005 280
12207885 Onorato TM et al.: Casein kinase II stimulates rat liver mitochondrial glycerophosphate acyltransferase activity Biochem. Biophys. Res. Commun. 2002 296: 1091-1096
15708364 Collison LW et al.: Aging reduces glycerol-3-phosphate acyltransferase activity in activated rat splenic T-lymphocytes Biochim. Biophys. Acta 2005 1-3: 164-172
12573444 Kannan L et al.: Aging and acyl-CoA binding protein alter mitochondrial glycerol-3-phosphate acyltransferase activity Biochim. Biophys. Acta 2003 1631: 12-16
10585467 Shimano H et al.: Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes J. Biol. Chem. 1999 274
11124951 Xu J et al.: Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay J. Biol. Chem. 2001 276: 9800-9807
10535992 Foretz M et al.: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes Proc. Natl. Acad. Sci. U.S.A. 1999 96
10570128 Shimomura I et al.: Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes Proc. Natl. Acad. Sci. U.S.A. 1999 96
10207099 Foretz M et al.: ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose Mol. Cell. Biol. 1999 5: 3760-3768
10949029 Shimomura I et al.: Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice Mol. Cell 2000 6: 77-86
9600904 Horton JD et al.: Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice Proc. Natl. Acad. Sci. U.S.A. 1998 95: 5987-5992
9421459 Kim JB et al.: Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1 J. Clin. Invest. 1998 101: 1-9
11679417 Becard D et al.: Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice Diabetes 2001 50: 2425-2430
11443121 Chakravarty K et al.: Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription J. Biol. Chem. 2001 276
10485707 Shimomura I et al.: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999 401: 73-76
10514488 Shimomura I et al.: Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus J. Biol. Chem. 1999 274
10973319 Lin HZ et al.: Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat. Med. 2000 6: 998-1003
11602624 Zhou G et al.: Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 2001 108: 1167-1174
11602624 Zhou G et al.: Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 2001 108: 1167-1174
19363290 Kammoun HL et al.: GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice J. Clin. Invest. 2009 5: 1201-1215
19363290 Kammoun HL et al.: GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice J. Clin. Invest. 2009 119: 1201-1215
9054427 Ericsson J et al.: Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. J. Biol. Chem. 1997 272: 7298-7305
9054427 Ericsson J et al.: Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene J. Biol. Chem. 1997 272: 7298-7305
18339309 Yazdi M et al.: The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice Biochem. Biophys. Res. Commun. 2008 369: 1065-1070
15102885 Linden D et al.: Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis J. Lipid Res. 2004 45: 1279-1288
16507761 Linden D et al.: Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation FASEB J. 2006 20: 434-443
11546763 Igal RA et al.: Mitochondrial glycerol phosphate acyltransferase directs the incorporation of exogenous fatty acids into triacylglycerol. J. Biol. Chem. 2001 276
17389595 Nagle CA et al.: Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance J. Biol. Chem. 2007 282
15598672 Lewin TM et al.: Mitochondrial glycerol-3-phosphate acyltransferase-1 directs the metabolic fate of exogenous fatty acids in hepatocytes Am. J. Physiol. Endocrinol. Metab. 2005 288: E835-E844
17258706 Hammond LE et al.: Increased oxidative stress is associated with balanced increases in hepatocyte apoptosis and proliferation in glycerol-3-phosphate acyltransferase-1 deficient mice Exp. Mol. Pathol. 2007 82: 210-219
7961630 Vancura A et al.: Purification and characterization of glycerophosphate acyltransferase from rat liver mitochondria J. Biol. Chem. 1994 269
17493869 Pellon-Maison M et al.: Mitochondrial glycerol-3-P acyltransferase 1 is most active in outer mitochondrial membrane but not in mitochondrial associated vesicles (MAV) Biochim. Biophys. Acta 2007 1771: 830-838
11716470 Lewin TM et al.: Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is unique in various rat tissues and is discordant with protein expression Arch. Biochem. Biophys. 2001 396: 119-127
14724270 Lewin TM et al.: Identification of a new glycerol-3-phosphate acyltransferase isoenzyme, mtGPAT2, in mitochondria J. Biol. Chem. 2004 279
17689486 Wang S et al.: Cloning and functional characterization of a novel mitochondrial N-ethylmaleimide-sensitive glycerol-3-phosphate acyltransferase (GPAT2) Arch. Biochem. Biophys. 2007 465: 347-358
17013544 Harada N et al.: Molecular cloning of a murine glycerol-3-phosphate acyltransferase-like protein 1 (xGPAT1) Mol. Cell. Biochem. 2007 297: 41-51
17170135 Cao J et al.: Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis. Proc. Natl. Acad. Sci. U.S.A. 2006 103
16436371 Vergnes L et al.: Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity J. Lipid Res. 2006 47: 745-754
12938015 Li D et al.: Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family. J. Hum. Genet. 2003 48: 438-442
18238778 Chen YQ et al.: AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase J. Biol. Chem. 2008 283
15247243 Kerner J et al.: Phosphorylation of rat liver mitochondrial carnitine palmitoyltransferase-I: effect on the kinetic properties of the enzyme J. Biol. Chem. 2004 279
6615474 Mills SE et al.: Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I. Biochem. J. 1983 214: 83-91
17147517 Sanders MJ et al.: Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade Biochem. J. 2007 403: 139-148
16308421 Shaw RJ et al.: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005 310: 1642-1646
15855317 Foretz M et al.: Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 2005 54: 1331-1339
12847291 Hong SP et al.: Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. U.S.A. 2003 100: 8839-8843
15793229 Pold R et al.: Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 2005 54: 928-934
15561958 Cleasby ME et al.: Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 2004 53: 3258-3266
11994296 Fryer LG et al.: The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002 277
14733947 Saha AK et al.: Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem. Biophys. Res. Commun. 2004 314: 580-585
12446579 Ye JM et al.: Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. Endocrinology 2002 143: 4527-4535
12368907 Yamauchi T et al.: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002 8: 1288-1295
12065578 Park H et al.: Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 2002 277
18390901 Gauthier MS et al.: AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J. Biol. Chem. 2008 283
18390901 Gauthier MS et al.: AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance J. Biol. Chem. 2008 283
18845612 Dzamko N et al.: AMPK-independent pathways regulate skeletal muscle fatty acid oxidation J. Physiol. (Lond.) 2008 586: 5819-5831
9693118 Salt I et al.: AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem. J. 1998 334: 177-187
12805220 Baas AF et al.: Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 2003 22: 3062-3072
16449762 Beigneux AP et al.: Agpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium J. Lipid Res. 2006 47: 734-744
14517248 Boudeau J et al.: MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 2003 22: 5102-5114
8549768 Davies SP et al.: 5-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett. 1995 377: 421-425
14511394 Hawley SA et al.: Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade J. Biol. 2003 2: 28
16054095 Hawley SA et al.: Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005 2: 9-19
15980064 Hurley RL et al.: The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 2005 280
18522808 Lewin TM et al.: Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition Biochim. Biophys. Acta 2008 1781: 352-358
16054096 Woods A et al.: Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005 2: 21-33
11287605 Yoshikawa T et al.: Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter Mol. Cell. Biol. 2001 9: 2991-3000
15956049 Assifi MM et al.: AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats Am. J. Physiol. Endocrinol. Metab. 2005 289: E794-E800
14976316 Banerjee RR et al.: Regulation of fasted blood glucose by resistin Science 2004 303: 1195-1198
19665995 Kim T et al.: Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem. Biophys. Res. Commun. 2009 388: 377-382
18420492 Cederroth CR et al.: Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism Diabetes 2008 57: 1176-1185
19237574 Chen Y et al.: Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimers amyloid peptides via up-regulating BACE1 transcription Proc. Natl. Acad. Sci. U.S.A. 2009 106: 3907-3912
18971390 Collison LW et al.: Glycerol-3-phosphate acyltransferase-1 regulates murine T-lymphocyte proliferation and cytokine production. Am. J. Physiol. 2008 295
15569818 Chen HC et al.: Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2005 25: 482-486
18167308 Bronnikov GE et al.: Acute effects of insulin on the activity of mitochondrial GPAT1 in primary adipocytes. Biochem. Biophys. Res. Commun. 2008 367: 201-207
10940327 Coleman RA et al.: Physiological and nutritional regulation of enzymes of triacylglycerol synthesis Annu. Rev. Nutr. 2000 20: 77-103
11597827 Adeli K et al.: Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc. Med. 2001 11: 170-176
18487474 Trenell MI et al.: Increased daily walking improves lipid oxidation without changes in mitochondrial function in type 2 diabetes. Diabetes Care 2008 31: 1644-1649
16614395 Dentin R et al.: Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP. J. Nutr. 2006 136: 1145-1149
18023282 Reue K et al.: The lipin protein family: dual roles in lipid biosynthesis and gene expression FEBS Lett. 2008 1: 90-96
16950137 Finck BN et al.: Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway Cell Metab. 2006 3: 199-210
19770177 Sugden MC et al.: PPAR control: its SIRTainly as easy as PGC J. Endocrinol. 2010 2: 93-104
18840364 Banks AS et al.: SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 2008 8: 333-341
12107756 Hara K et al.: A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes Diabetologia 2002 45: 740-743
19254570 Nagai Y et al.: The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab. 2009 9: 252-264
18046409 Milne JC et al.: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007 450: 712-716
18599449 Pfluger PT et al.: Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U.S.A. 2008 105: 9793-9798
19549853 Erion DM et al.: SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc. Natl. Acad. Sci. U.S.A. 2009 106
18849969 Liu Y et al.: A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 2008 456: 269-273
19356714 Purushotham A et al.: Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation Cell Metab. 2009 4: 327-338
19041393 Frojdo S et al.: Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans Biochim. Biophys. Acta 2009 2: 83-92
17268085 Na M et al.: Protein tyrosine phosphatase 1B inhibitory activity of amentoflavone and its cellular effect on tyrosine phosphorylation of insulin receptors. Biol. Pharm. Bull. 2007 30: 379-381
18281274 Zabolotny JM et al.: Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem. 2008 283
16461936 Lam NT et al.: Leptin resistance following over-expression of protein tyrosine phosphatase 1B in liver. J. Mol. Endocrinol. 2006 36: 163-174
16845389 Bence KK et al.: Neuronal PTP1B regulates body weight, adiposity and leptin action Nat. Med. 2006 12: 917-924
15189365 Santaniemi M et al.: Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes. J. Intern. Med. 2004 256: 48-55
15715684 Gouni-Berthold I et al.: The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population. J. Intern. Med. 2005 257: 272-280
10660596 Goldstein BJ et al.: Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J. Biol. Chem. 2000 275: 4283-4289
15031294 Zabolotny JM et al.: Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action J. Biol. Chem. 2004 279
18053812 de Luca C et al.: Inflammation and insulin resistance FEBS Lett. 2008 582: 97-105
10542212 Schottelius AJ et al.: Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding J. Biol. Chem. 1999 45
12228220 Rui L et al.: SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 2002 277
11001060 Baumann CA et al.: CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000 407: 202-207
7738205 Hotamisligil GS et al.: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995 95: 2409-2415
10591334 Visser M et al.: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999 282: 2131-2135
8662983 Peraldi P et al.: Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 1996 271
9335502 Uysal KT et al.: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997 389: 610-614
8995390 Stephens JM et al.: Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction J. Biol. Chem. 1997 272: 971-976
16818881 Tuncman G et al.: Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance Proc. Natl. Acad. Sci. U.S.A. 2006 103
9817203 Yin MJ et al.: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta Nature 1998 396: 77-80